{"gene":"MAP2K6","run_date":"2026-04-28T18:30:27","timeline":{"discoveries":[{"year":1996,"finding":"MKK6 (MAP2K6) was identified as a novel MAP kinase kinase that selectively phosphorylates and activates p38 MAPK, but not ERK or JNK family members, as demonstrated by direct kinase assays and co-transfection studies. Two human splice isoforms (278 and 334 aa) and one murine isoform were cloned.","method":"cDNA cloning, co-transfection assays, direct in vitro kinase assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — in vitro kinase assay with multiple isoforms, replicated by multiple labs","pmids":["8621675","8626699"],"is_preprint":false},{"year":1996,"finding":"SAPKK3/MKK6 was purified from rabbit skeletal muscle as the major activator of RK/p38 in stress- and cytokine-stimulated monocytes and epithelial cells; it activates p38 but not JNK/SAPK in vitro.","method":"Protein purification to near homogeneity, tryptic peptide sequencing, cDNA cloning, in vitro kinase assay","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 — biochemical purification combined with in vitro reconstitution","pmids":["8861944"],"is_preprint":false},{"year":1997,"finding":"MKK6 (SAPKK3) selectively activates SAPK3/p38gamma and SAPK4/p38delta in response to cytokines and cellular stresses, and is the only activator of these isoforms induced by IL-1 or stress in KB cells. MKK6 mediates phosphorylation of ATF2, Elk-1 and SAP-1 through these downstream kinases.","method":"In vitro kinase assay, co-transfection in COS cells, immunoprecipitation kinase assay","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution replicated in two independent papers","pmids":["9029150","9218798"],"is_preprint":false},{"year":1998,"finding":"MKK6 is identified as a common activator of p38α, p38β2, and p38γ isoforms, while MKK3 activates only p38α and p38γ, defining selective coupling between upstream kinases and p38 isoforms.","method":"Molecular cloning, co-transfection assays, in vitro kinase assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — replicated across multiple labs with direct kinase assays","pmids":["9430721"],"is_preprint":false},{"year":1998,"finding":"In Fas signaling, MKK6 is the major upstream activator of p38, acting independently of CPP32-like proteases; MKK7 (not MKK4/SEK1) activates JNK in the same pathway, establishing pathway-specific MKK usage downstream of Fas.","method":"Immunoprecipitation kinase assay, peptide inhibitor experiments, co-transfection","journal":"The Journal of cell biology","confidence":"Medium","confidence_rationale":"Tier 2 — reciprocal pathway dissection with specific inhibitors, single lab","pmids":["9362518"],"is_preprint":false},{"year":1998,"finding":"MKK6 (constitutively active MKK6(Glu)) selectively activates p38 in cardiac myocytes, protecting them from apoptosis in a p38-dependent manner and activating NF-κB transcription; anti-apoptotic effect is blocked by SB203580.","method":"Overexpression of constitutively active MKK6(Glu) in primary neonatal rat ventricular myocytes, SB203580 inhibition, NF-κB reporter assay, cell death assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — clean gain-of-function with pharmacological validation and specific cellular phenotype","pmids":["9525929"],"is_preprint":false},{"year":1998,"finding":"MKK6 is activated by T cell receptor signaling and is required for p38-dependent IL-2 promoter transcriptional activation; dominant-negative MKK6 suppresses IL-2 promoter activity; both MKK6-p38 and MKK7-JNK pathways are inhibited by cyclosporin A.","method":"Dominant-negative mutant expression, luciferase reporter assay, kinase assay in T lymphocytes","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — dominant-negative approach with reporter assay, single lab","pmids":["9575191"],"is_preprint":false},{"year":1998,"finding":"In TNF signaling, RIP (receptor interacting protein) associates with an endogenous MAPKKK that activates MKK6 and the p38 pathway in vitro; TRAF2 activation of p38 requires RIP, placing RIP upstream of MKK6.","method":"In vivo binding assays, in vitro kinase cascade assay, co-expression studies","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — in vitro pathway reconstitution, single lab","pmids":["9712898"],"is_preprint":false},{"year":1999,"finding":"MEKK3 (and MEKK2) directly phosphorylate and activate MKK6 in vitro, identifying MEKK3 as a MAP3K upstream of MKK6 in the p38 pathway; immunoprecipitated MEKK3 directly activated recombinant MKK6 in cell-free assays.","method":"Co-expression in COS-7 cells, in vitro kinase assay with immunoprecipitated MEKK3/MKK6, MAPKAPK2 phosphorylation assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — direct in vitro reconstitution of upstream→MKK6 phosphorylation","pmids":["10347227"],"is_preprint":false},{"year":1999,"finding":"The MKK6/p38 pathway is required for TNF-α-induced MCP-1 expression in endothelial cells; dominant-negative MKK6 strongly inhibits MCP-1, and constitutively active MKK6 enhances it, as shown by flow cytometry, Northern blot, and luciferase reporter assays.","method":"Dominant-negative and constitutively active MKK6 expression, flow cytometry, Northern blot, luciferase reporter assay","journal":"Blood","confidence":"Medium","confidence_rationale":"Tier 2 — multiple orthogonal methods, single lab","pmids":["9920834"],"is_preprint":false},{"year":1999,"finding":"Constitutively active MKK6 (MKK6(Glu)) is sufficient to drive spontaneous adipogenesis of 3T3-L1 fibroblasts in the absence of hormonal inducers, demonstrating that p38 activation via MKK6 is sufficient for the adipogenic differentiation program.","method":"Inducible expression system for MKK6(Glu), Oil Red O staining, morphological analysis in 3T3-L1 and NIH-3T3 cells","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — clean gain-of-function with specific differentiation phenotype, single lab","pmids":["10585441"],"is_preprint":false},{"year":2000,"finding":"Activation of the MKK6-p38γ cascade, but not other p38 isoforms, is required and sufficient for γ-irradiation-induced G2 cell cycle arrest; dominant-negative MKK6 or p38γ abrogates the DNA damage-induced G2 delay; MKK6 activation is ATM-dependent and leads to Cds1/Chk2 activation.","method":"Dominant-negative allele expression, gamma-irradiation, cell cycle analysis, epistasis with ATM","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis with specific isoform selectivity and defined signaling cascade, replicated with multiple dominant-negative alleles","pmids":["10848581"],"is_preprint":false},{"year":2000,"finding":"MKK6(Glu) induces p38-dependent transcriptional upregulation and phosphorylation of αB-crystallin on serine-59 (via MAPKAP-K2) in cardiac myocytes, providing cytoprotection against stress-induced apoptosis.","method":"Constitutively active MKK6(Glu) overexpression, Northern/Western blot, in vitro kinase assay, apoptosis assay in cardiac myocytes","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — multiple assay types, defined downstream phosphorylation site identified","pmids":["10816593"],"is_preprint":false},{"year":2000,"finding":"IL-12 activates p38 which, together with MKK6, phosphorylates STAT4 on serine 721 to drive full STAT4 transcriptional activity; mutation of Ser721 abrogates IL-12-induced transcription, establishing an MKK6/p38α/STAT4 signaling axis.","method":"Co-transfection, in vitro kinase assay, site-directed mutagenesis (S721A), luciferase reporter, dominant-negative MKK6","journal":"Blood","confidence":"High","confidence_rationale":"Tier 1 — in vitro phosphorylation, site-directed mutagenesis, and functional reporter assay","pmids":["10961885"],"is_preprint":false},{"year":2001,"finding":"G protein Gαq activates MKK6 in a Rho-dependent manner, while Gβγ activates MKK6 via Rho-, Rac-, and Cdc42-dependent pathways; kinase-deficient MKK6 blocks p38 activation by Gαq and Gβγ, placing MKK6 downstream of Gq-coupled receptors.","method":"Kinase-deficient mutant expression in HEK293 cells, p38 activity assay, GTPase dependency studies","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — epistasis with dominant-negative mutants, single lab","pmids":["11304531"],"is_preprint":false},{"year":2001,"finding":"MKK6/MKK3-p38 MAPK pathway activation by constitutively active MKK6 upregulates GLUT1 and downregulates GLUT4 expression in adipocytes and myotubes, increasing basal glucose transport while reducing insulin-stimulated uptake; p38 activation is not required for insulin-induced glucose uptake itself.","method":"Adenovirus-mediated expression of constitutively active/dominant-negative MKK6 and MKK3, glucose uptake assay, Western blot in 3T3-L1 adipocytes and L6 myotubes","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — orthogonal gain- and loss-of-function, multiple cell types","pmids":["11279172"],"is_preprint":false},{"year":2002,"finding":"MKK6 is specifically required for deletion of double-positive thymocytes in vivo (negative selection), while MKK3 (not MKK6) is required for activation-induced cell death and cytokine withdrawal-induced apoptosis of peripheral CD4+ T cells; established using Mkk6-/- and Mkk3-/- mice.","method":"Mkk6 knockout mouse generation, thymocyte deletion assay, T cell apoptosis assays","journal":"EMBO reports","confidence":"High","confidence_rationale":"Tier 2 — clean knockout mouse with specific and distinct in vivo phenotype","pmids":["12151339"],"is_preprint":false},{"year":2003,"finding":"p38α negatively regulates MKK6 mRNA stability via the 3'UTR of MKK6 mRNA, forming a negative feedback loop; p38α-/- cells have elevated MKK6 mRNA and protein; reintroduction of p38α normalizes MKK6 levels.","method":"p38α knockout MEFs, pharmacological p38α inhibition, mRNA stability assay, 3'UTR reporter assay","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 — knockout cells + rescue experiment + 3'UTR reporter, multiple orthogonal methods","pmids":["12482988"],"is_preprint":false},{"year":2003,"finding":"MKK6-p38 MAPK pathway activation prolongs cardiac contractile calcium transients by downregulating SERCA2 expression, increasing diastolic [Ca2+]i and activating NF-AT; SERCA2 overexpression reverses these effects.","method":"MKK6(Glu) overexpression in neonatal rat ventricular myocytes, indo-1 calcium imaging, Northern/Western blot, SERCA2 reporter assay, NF-AT reporter","journal":"Cardiovascular research","confidence":"Medium","confidence_rationale":"Tier 2 — multiple orthogonal methods, single lab with rescue experiment","pmids":["12829175"],"is_preprint":false},{"year":2004,"finding":"PKR (double-stranded RNA-activated protein kinase) interacts with and directly phosphorylates MKK6 (but not MKK3 or MKK4) following dsRNA stimulation, providing a mechanism for p38 activation in the dsRNA response.","method":"Co-immunoprecipitation, in vitro kinase assay, coupled kinase assay, kinase-inactive PKR dominant-negative, PKR-null cells","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — in vitro phosphorylation reconstitution + genetic validation with KI mutant","pmids":["15229216"],"is_preprint":false},{"year":2005,"finding":"MEKK3 activates MKK6 and p38 in the p38 pathway in intact cells; anisomycin, sorbitol, or MEKK3 expression all activate MAPKAPK2 in a p38/SB203580-sensitive manner, confirming MEKK3→MKK6→p38 as a physiologically relevant cascade.","method":"Co-expression in COS-7 and HEK293 cells, in vitro kinase assay, SB203580 inhibition","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — in vitro assay confirmed in intact cells with pharmacological validation","pmids":["10347227"],"is_preprint":false},{"year":2005,"finding":"Selectivity pocket inhibitors of p38α (e.g., BIRB796) that stabilize a DFG-out conformation prevent MKK6-dependent phosphorylation/activation of p38α, while purine-site-only inhibitors do not; crystal structures of seven inhibitor complexes were solved, showing the activation loop displacement that blocks MKK6 recognition.","method":"Kinetic analysis, novel cell-free MKK6-dependent p38α activation assay, crystal structures (4 new), cellular TNFα inhibition assay","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 — crystal structures combined with in vitro mechanistic assay","pmids":["16342939"],"is_preprint":false},{"year":2005,"finding":"Type I interferons (IFNα/β) activate both MKK3 and MKK6, which are required for downstream p38 activation and for IFN-dependent gene transcription (Isg15, Irf-9) via a STAT-independent mechanism, as shown using MKK3-/-/MKK6-/- double-knockout MEFs.","method":"Double-knockout MEFs, luciferase reporter assay, kinase assay, qPCR","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — double-knockout genetic model with multiple functional readouts","pmids":["15644321"],"is_preprint":false},{"year":2006,"finding":"TAK1 and MKK6 (but not MKK3) are required for RANKL-induced NFATc1 induction and NF-κB transactivation (via p65 Ser-536 phosphorylation) during osteoclast differentiation; dominant-negative TAK1 and MKK6 both impair osteoclastogenesis.","method":"Retroviral transduction of dominant-negative kinases, RANKL-stimulated primary bone marrow cells, NFATc1 and NF-κB reporter assays, Western blot","journal":"Cell death and differentiation","confidence":"Medium","confidence_rationale":"Tier 2 — dominant-negative epistasis with primary cells and multiple readouts, single lab","pmids":["16498455"],"is_preprint":false},{"year":2007,"finding":"MKK6-p38 signaling in inflammation-activated muscle progenitors recruits the SWI/SNF chromatin-remodeling complex to muscle gene promoters; MKK6/p38 and IGF1/PI3K/AKT pathways converge on chromatin of muscle genes to regulate distinct components of the myogenic transcriptosome.","method":"Chromatin immunoprecipitation, genetic and pharmacological inhibition of p38 and AKT, MEF2-SWI/SNF complex assembly assays","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 2 — ChIP-based mechanistic dissection with multiple genetic perturbations","pmids":["17964260"],"is_preprint":false},{"year":2007,"finding":"TNF-α stabilizes SOCS3 mRNA via activation of the MKK6/p38MAPK/MK2 cascade; in MK2-deficient fibroblasts and macrophages, basal SOCS3 expression is reduced and TNF-α-induced SOCS3 mRNA stabilization is impaired. The 3'UTR AUUUA/U-rich region (positions 2422–2541) of SOCS3 is identified as the regulatory target.","method":"MK2 knockout cells, mRNA stability assay, 3'UTR mapping, dominant-negative MKK6 expression","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 — knockout validation + 3'UTR mapping + multiple cell types","pmids":["17312125"],"is_preprint":false},{"year":2007,"finding":"Constitutively active MKK6 in chondrocytes in vivo (transgenic mice) reduces chondrocyte proliferation, inhibits hypertrophic differentiation, delays ossification, and increases Sox9 transcriptional activity; p38 signaling increases Sox9 transactivation in transfected cells, suggesting Sox9 is a downstream target of MKK6-p38 in endochondral ossification.","method":"Transgenic mouse generation, in situ hybridization, histology, co-transfection reporter assay for Sox9","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — in vivo transgenic gain-of-function with mechanistic in vitro follow-up","pmids":["16387856"],"is_preprint":false},{"year":2007,"finding":"MKK6 phosphorylation (especially Tyr219) enhances Rac GTPase activity; constitutively active MKK6 directly interacts with Rac1 in vitro and inhibits PMA-induced NADPH oxidase activation in RAW cells; MKK6 deficiency leads to increased Rac1-GTP levels in brain tissue.","method":"Co-immunoprecipitation under redox stress, in vitro kinase assay, site-directed mutagenesis (Y219F), NADPH oxidase activity assay, MKK6 knockout brain tissue","journal":"Antioxidants & redox signaling","confidence":"Medium","confidence_rationale":"Tier 2 — in vitro binding + mutagenesis + knockout validation","pmids":["17854274"],"is_preprint":false},{"year":2009,"finding":"The crystal structure of the MEK6/MAP2K6 kinase domain (phosphomimetic DD mutant, 2.3 Å) reveals an autoinhibited elongated dimer; the interface includes the phosphate-binding ribbon, activation loop, and an arginine stack; the dimer conformation prevents activation loop phosphorylation by inappropriate kinases. Solution SAXS confirms the dimer.","method":"X-ray crystallography (2.3 Å), gel filtration, SAXS","journal":"Structure","confidence":"High","confidence_rationale":"Tier 1 — crystal structure with solution validation","pmids":["19141286"],"is_preprint":false},{"year":2009,"finding":"Using MKK3-/-, MKK6-/-, and double-knockout cells, MKK3 and MKK6 are both required for stress-induced p38γ and p38β activation, while MKK6 is the major p38γ activator in response to TNFα; p38δ activation by UV, osmotic shock, anisomycin, and TNFα is mediated selectively by MKK3.","method":"MKK knockout fibroblasts, kinase activity assays, phosphorylation of downstream substrate hDlg","journal":"Cellular signalling","confidence":"High","confidence_rationale":"Tier 2 — genetic knockout panel with isoform-specific readouts","pmids":["20004242"],"is_preprint":false},{"year":2010,"finding":"ASK1 phosphorylates MKK6 in response to oxidative stress (H2O2); H2O2 treatment increases ASK1 catalytic efficiency for MKK6 ~4000-fold primarily by decreasing Km(MKK6) ~1000-fold; MKK6 co-purifies within the ASK1 signalosome in a transient, stress-regulated manner.","method":"In vitro kinetic analysis, immunoprecipitation, high-molecular mass complex purification from intact cells","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 — quantitative in vitro kinetics + cell-based signalosome purification","pmids":["20364819"],"is_preprint":false},{"year":2010,"finding":"LRRK2 (Parkinson's disease kinase) binds to MKK6 and phosphorylates MKK6 in vitro; co-expression of LRRK2 and MKK6 increases steady-state levels of each protein and increases MKK6 membrane localization; disease-linked LRRK2 mutations (G2019S, R1441C, I2020T) enhance binding to MKK6.","method":"Co-immunoprecipitation, in vitro kinase assay, subcellular fractionation, C. elegans RNAi epistasis","journal":"Journal of neurochemistry","confidence":"Medium","confidence_rationale":"Tier 2 — Co-IP + in vitro phosphorylation + in vivo epistasis, single lab","pmids":["20067578"],"is_preprint":false},{"year":2010,"finding":"Constitutively active MKK6 in melanocytes induces dendrite elongation via upregulation of Cdc42 and Rac1 (Rho family GTPases), identifying MKK6 as an upstream regulator of dendricity through this GTPase pathway.","method":"Adenovirus-mediated constitutively active MKK6 overexpression, morphometric analysis, Western blot in SK-mel-24 melanoma and primary human melanocytes","journal":"Journal of dermatological science","confidence":"Low","confidence_rationale":"Tier 3 — overexpression phenotype, no direct MKK6→GTPase phosphorylation shown","pmids":["20869211"],"is_preprint":false},{"year":2012,"finding":"Crystal structure of non-phosphorylated human MAP2K6 complexed with an ATP analogue (2.6 Å) reveals three activation-loop α-helices (AH1, AH2, AH3) that enforce auto-inhibition: AH1 displaces the αC-helix and AH1/AH2 enclose the ATP γ-phosphate, representing a unique auto-inhibition mechanism distinct from MAP2K1 and MAP2K4.","method":"X-ray crystallography (2.6 Å), structural comparison","journal":"Journal of biochemistry","confidence":"High","confidence_rationale":"Tier 1 — crystal structure with mechanistic interpretation","pmids":["22383536"],"is_preprint":false},{"year":2013,"finding":"β-Amyloid activates MKK6 (phosphorylation at Ser207), which then directly phosphorylates p66shc at Ser36; MKK6 physically associates with p66shc (co-IP), and this MKK6-p66shc complex mediates β-amyloid-evoked ROS production and apoptotic cell death.","method":"Co-immunoprecipitation, site-directed mutagenesis, MKK6 knockdown, ROS assay, apoptosis assay","journal":"Neuromolecular medicine","confidence":"Medium","confidence_rationale":"Tier 2 — Co-IP + mutagenesis + knockdown with defined phenotype, single lab","pmids":["24085465"],"is_preprint":false},{"year":2014,"finding":"FBXO31, a component of SCF E3 ubiquitin ligase, binds MKK6 and mediates its Lys48-linked polyubiquitination and proteasomal degradation, functioning as a negative regulator of MKK6-p38 signaling upon genotoxic stress.","method":"Co-immunoprecipitation, ubiquitination assay (K48-specific), proteasome inhibitor studies, loss-of-function in cancer cells","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — Co-IP + ubiquitination assay + functional rescue, single lab","pmids":["24936062"],"is_preprint":false},{"year":2016,"finding":"TPL-2 (MAP3K8) kinase activity is required for TLR4 and TNF receptor activation of MKK3/6 phosphorylation in macrophages, downstream of IKK-mediated phosphorylation of NF-κB1 p105; established by quantitative mass spectrometry comparing wild-type and kinase-inactive TPL-2 knock-in macrophages.","method":"Quantitative phosphoproteomics (mass spectrometry), kinase-inactive knock-in mice, macrophage stimulation assays","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 1 — quantitative phosphoproteomics in genetic model, replicated across multiple TLR stimuli","pmids":["27402796"],"is_preprint":false},{"year":2016,"finding":"miR-625-3p directly targets MAP2K6 mRNA (validated by luciferase reporter), reducing MAP2K6-p38 signaling and inducing oxaliplatin resistance in colorectal cancer cells; resistance is reversed by anti-miR-625-3p treatment or ectopic expression of a miR-625-3p-insensitive MAP2K6 variant.","method":"Luciferase reporter assay, siRNA, dominant-negative MAP2K6, transcriptome/proteome/phosphoproteome profiling, functional rescue","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 — luciferase validation + orthogonal rescue experiment + multi-omics confirmation","pmids":["27526785"],"is_preprint":false},{"year":2017,"finding":"MKK6 is elevated in white adipose tissue of obese individuals; Mkk6 deletion in mice increases thermogenic capacity and UCP1 expression in WAT via T3 stimulation, protecting against diet-induced obesity; mechanistically, p38 is activated in WAT through an alternative pathway involving AMPK-TAK-TAB rather than MKK6.","method":"MKK6 knockout mice, shRNA knockdown, UCP1 expression assay, metabolic phenotyping, pathway dissection with specific inhibitors","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 — genetic knockout with in vivo metabolic phenotype and mechanistic pathway identification","pmids":["29021624"],"is_preprint":false},{"year":2018,"finding":"TRIM9 short isoform (TRIM9s) stabilizes MKK6 by promoting K63-linked ubiquitination at Lys82, thereby blocking competing degradative K48-linked ubiquitination at the same lysine; MKK6 in turn stabilizes TRIM9s via p38-dependent phosphorylation at Ser76/80, forming a positive feedback loop that enhances p38 signaling.","method":"Co-immunoprecipitation, ubiquitination assay (K48 vs K63 linkage), mutagenesis (Lys82, Ser76/80), phosphorylation assay","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 1 — site-specific ubiquitination and phosphorylation mapping with mutagenesis","pmids":["29669288"],"is_preprint":false},{"year":2018,"finding":"Gossypetin directly inhibits MKK3 and MKK6 protein kinase activity in vitro; Arg61 in MKK6 is critical for gossypetin binding as shown by mutagenesis; inhibition is dependent on MKK3/6 expression in cells.","method":"In vitro kinase assay, computational docking, site-directed mutagenesis (R61), cell growth assays","journal":"Cancer letters","confidence":"Medium","confidence_rationale":"Tier 1 — in vitro kinase assay + mutagenesis, single lab","pmids":["30391783"],"is_preprint":false},{"year":2020,"finding":"Optical activation (uncaging) of MKK6 in fibroblasts is sufficient to trigger p38-dependent apoptosis and potently inhibits ERK/pro-proliferative signaling; the ERK pathway inhibition by MKK6 is equally robust even when all p38 isoforms are pharmacologically inhibited, revealing a p38-independent negative cross-regulatory function of MKK6.","method":"Caged lysine light-activatable kinase expression, p38 inhibition, ERK pathway readout, apoptosis assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — novel optogenetic kinase activation with pharmacological dissection of p38-dependent vs -independent effects","pmids":["32371393"],"is_preprint":false},{"year":2021,"finding":"MKK6 phosphorylates Gatad2b as a novel substrate (independent of p38), promoting K9 histone acetylation and heterochromatin loosening to facilitate somatic cell reprogramming; this requires MKK6 kinase activity but not its canonical p38 target.","method":"Overexpression/knockdown during iPSC reprogramming, kinase activity assays, ATAC-seq, ChIP, identification of Gatad2b as MKK6 substrate","journal":"Cell death and differentiation","confidence":"Medium","confidence_rationale":"Tier 2 — identification of novel substrate with functional chromatin readout, single lab","pmids":["34815549"],"is_preprint":false},{"year":2021,"finding":"NMR spectroscopy and ITC define the binding interface between full-length MKK6 and p38: MKK6 engages p38 via the hydrophobic docking groove and influences helix αF; the conserved docking (CD) site of p38 is much less affected by MKK6 than by phosphatases; MKK6 binding is independent of its activation state.","method":"NMR spectroscopy, isothermal titration calorimetry (ITC)","journal":"Protein science","confidence":"High","confidence_rationale":"Tier 1 — structural NMR with thermodynamic validation defines molecular binding interface","pmids":["33554397"],"is_preprint":false},{"year":2022,"finding":"MKK6 deficiency in mice blunts p38α activation while causing MKK3-p38γ/δ hyperphosphorylation and elevated mTOR signaling, leading to cardiac hypertrophy that progresses to dilatation and fibrosis; cardiac hypertrophy is reversed by p38γ or p38δ knockout or rapamycin treatment, identifying MKK3/6-p38γ/δ-mTOR as a cardiac hypertrophy pathway.","method":"MKK6 knockout mice, longitudinal cardiac function analysis, p38γ/p38δ double knockout rescue, rapamycin treatment, kinase assays","journal":"eLife","confidence":"High","confidence_rationale":"Tier 2 — in vivo genetic epistasis with pharmacological rescue, multiple orthogonal validations","pmids":["35971771"],"is_preprint":false},{"year":2022,"finding":"PPM1G phosphatase directly dephosphorylates MEK6 (phospho-MEK6 identified as direct PPM1G substrate), reducing p38 activation and promoting lung adenocarcinoma proliferation and metastasis.","method":"Phosphoproteomics, in vitro dephosphorylation assay, co-immunoprecipitation, loss-of-function in cancer cells","journal":"Carcinogenesis","confidence":"Medium","confidence_rationale":"Tier 2 — direct substrate identification in vitro + functional cellular readout, single lab","pmids":["36349938"],"is_preprint":false},{"year":2023,"finding":"Cryo-EM structure of the MKK6-p38α complex combined with molecular dynamics simulations, HDX-MS, and cell experiments reveals a dynamic multistep dual-phosphorylation mechanism; MKK6's disordered N-terminus determines pathway specificity; catalytically relevant interaction interfaces were identified.","method":"Cryo-electron microscopy, molecular dynamics simulation, hydrogen-deuterium exchange mass spectrometry, cell-based assays","journal":"Science","confidence":"High","confidence_rationale":"Tier 1 — cryo-EM structure with MD and HDX-MS validation, multidisciplinary approach","pmids":["37708276"],"is_preprint":false}],"current_model":"MAP2K6 (MKK6) is a dual-specificity kinase that functions as the primary upstream activator of p38α, p38β, p38γ, and p38δ MAPKs through dual phosphorylation of their TGY activation loop motif; its cryo-EM structure with p38α reveals a dynamic multistep phosphorylation mechanism where MKK6's disordered N-terminus determines pathway specificity, while its autoinhibited dimeric crystal structure explains how the unphosphorylated enzyme prevents premature activation. MKK6 is itself activated by MAP3Ks including MEKK3, ASK1, and TAK1 in response to stress, cytokines, and dsRNA (via PKR), and is negatively regulated by FBXO31-mediated K48 ubiquitination/degradation, PPM1G dephosphorylation, and p38α-dependent destabilization of its own mRNA. Beyond canonical p38 signaling, MKK6 also phosphorylates non-p38 substrates (Gatad2b, p66shc), interacts with Rac1 to enhance GTPase activity, and exerts p38-independent inhibition of ERK signaling, making it a pleiotropic stress-signaling node controlling inflammation, apoptosis, cell cycle arrest, differentiation, and chromatin remodeling."},"narrative":{"teleology":[{"year":1996,"claim":"Identification of MKK6 as a selective p38 MAPK activator resolved the question of which MAP2K relays stress/cytokine signals specifically to p38 rather than ERK or JNK, establishing the specificity principle of MAPK cascades.","evidence":"cDNA cloning, co-transfection, and direct in vitro kinase assays in multiple labs; biochemical purification from rabbit skeletal muscle","pmids":["8621675","8626699","8861944"],"confidence":"High","gaps":["Relative contributions of MKK6 vs MKK3 to p38 activation in specific tissues were not resolved","Upstream MAP3Ks for MKK6 were unknown"]},{"year":1997,"claim":"Demonstration that MKK6 activates p38γ and p38δ (in addition to p38α/β) while MKK3 cannot activate p38β2 established MKK6 as the broadest-spectrum p38 activator and defined isoform-specific coupling rules.","evidence":"In vitro kinase assays and co-transfection in COS cells with all four p38 isoforms","pmids":["9029150","9218798","9430721"],"confidence":"High","gaps":["Whether isoform selectivity held in vivo with endogenous expression levels was untested","Structural basis for broader substrate range of MKK6 vs MKK3 was unknown"]},{"year":1998,"claim":"Placement of MKK6 downstream of specific receptor systems—Fas, TCR, TNF/RIP/TRAF2, and Gq-coupled receptors—and demonstration that constitutively active MKK6(Glu) confers p38-dependent anti-apoptotic or pro-inflammatory effects established MKK6 as a critical signaling node in immune and cardiac cell biology.","evidence":"Dominant-negative MKK6 epistasis, constitutively active MKK6(Glu) gain-of-function, reporter assays, and pharmacological inhibition in T cells, monocytes, endothelial cells, and cardiac myocytes","pmids":["9362518","9575191","9712898","9525929"],"confidence":"Medium","gaps":["Direct MAP3K→MKK6 phosphorylation was not reconstituted","Endogenous protein-level validation was limited in most systems"]},{"year":1999,"claim":"Identification of MEKK3 as a MAP3K that directly phosphorylates and activates MKK6 in vitro filled the gap between upstream signals and MKK6 activation, completing a three-tier MEKK3→MKK6→p38 cascade.","evidence":"In vitro kinase assay with immunoprecipitated MEKK3 and recombinant MKK6, cascade reconstitution to MAPKAPK2 in COS-7 cells","pmids":["10347227"],"confidence":"High","gaps":["Physiological contexts requiring MEKK3 vs other MAP3Ks for MKK6 activation were unclear","Other MAP3Ks capable of activating MKK6 had not been systematically identified"]},{"year":2000,"claim":"Discovery that MKK6–p38γ mediates ATM-dependent G2 arrest after γ-irradiation and that MKK6–p38/MAPKAPK2 phosphorylates αB-crystallin for cytoprotection expanded MKK6 function beyond inflammation to DNA damage response and proteostasis.","evidence":"Dominant-negative alleles for MKK6 and p38γ, cell cycle analysis after irradiation, epistasis with ATM; constitutively active MKK6(Glu) in cardiac myocytes with phospho-site mapping","pmids":["10848581","10816593"],"confidence":"High","gaps":["Direct ATM→MKK6 phosphorylation was not shown","Whether p38γ-selective G2 arrest generalizes beyond HeLa cells was untested"]},{"year":2002,"claim":"Generation of Mkk6 knockout mice revealed a non-redundant requirement for MKK6 in thymocyte negative selection, distinct from MKK3's role in peripheral T cell apoptosis, establishing in vivo isoform specificity.","evidence":"Mkk6−/− and Mkk3−/− mice, thymocyte deletion assays, peripheral T cell death assays","pmids":["12151339"],"confidence":"High","gaps":["Molecular basis for MKK6's exclusive role in thymic deletion vs MKK3 in peripheral apoptosis was unknown","Compensatory mechanisms in double-knockout mice were not examined"]},{"year":2003,"claim":"Identification of a p38α-mediated negative feedback loop that destabilizes MKK6 mRNA via its 3′UTR revealed autoregulation of MAPK cascade amplitude and explained elevated MKK6 in p38α-null cells.","evidence":"p38α−/− MEFs, mRNA stability assays, 3′UTR luciferase reporters, rescue by p38α re-expression","pmids":["12482988"],"confidence":"High","gaps":["RNA-binding protein(s) mediating p38α-dependent MKK6 mRNA decay were not identified","Whether this feedback operates in all tissues was unknown"]},{"year":2004,"claim":"Demonstration that PKR directly phosphorylates MKK6 (but not MKK3/4) upon dsRNA stimulation identified a unique MAP3K-like activator linking innate antiviral sensing to p38 signaling.","evidence":"In vitro kinase assay, coupled kinase cascade, PKR−/− cells, kinase-inactive PKR dominant-negative","pmids":["15229216"],"confidence":"High","gaps":["Phosphorylation sites on MKK6 targeted by PKR were not mapped","Contribution of PKR–MKK6 axis relative to conventional MAP3Ks in vivo was unclear"]},{"year":2005,"claim":"Structural analysis of p38α inhibitors showed that DFG-out conformation stabilizers block MKK6-dependent p38α activation by displacing the activation loop, providing mechanistic insight into how substrate conformation gates upstream kinase access.","evidence":"Crystal structures of seven p38α-inhibitor complexes, cell-free MKK6-dependent p38α activation assay, cellular TNFα inhibition","pmids":["16342939"],"confidence":"High","gaps":["No co-crystal of MKK6 with p38α was available at this time","Whether DFG-out inhibitors affect MKK6 interaction with other p38 isoforms was not tested"]},{"year":2007,"claim":"MKK6 was found to interact directly with Rac1 and modulate its GTPase activity, and to recruit SWI/SNF chromatin remodelers to muscle gene promoters via p38, expanding MKK6's roles beyond canonical MAPK signaling to include GTPase regulation and chromatin remodeling.","evidence":"Co-IP of MKK6–Rac1, Y219F mutagenesis, NADPH oxidase assays in MKK6−/− tissue; ChIP for SWI/SNF complex on muscle gene promoters with p38 pathway perturbation","pmids":["17854274","17964260"],"confidence":"Medium","gaps":["Whether MKK6 phosphorylates Rac1 directly was not established","Whether SWI/SNF recruitment requires direct p38-mediated phosphorylation of SWI/SNF subunits was untested"]},{"year":2009,"claim":"The crystal structure of the MKK6 kinase domain revealed an autoinhibited elongated dimer whose interface occludes the activation loop, explaining how MKK6 prevents spurious activation and providing the first atomic model of a MAP2K autoinhibitory mechanism.","evidence":"X-ray crystallography at 2.3 Å (phosphomimetic DD mutant), SAXS confirmation of dimer in solution","pmids":["19141286"],"confidence":"High","gaps":["How MAP3K binding disrupts the autoinhibitory dimer was unknown","Whether the dimer exists under physiological concentrations in cells was not shown"]},{"year":2010,"claim":"Quantitative kinetics of ASK1-mediated MKK6 phosphorylation showed that oxidative stress increases ASK1's catalytic efficiency for MKK6 ~4000-fold (primarily by decreasing Km ~1000-fold), revealing a stress-regulated substrate recruitment mechanism within the ASK1 signalosome.","evidence":"In vitro kinetic analysis, immunoprecipitation, high-MW signalosome purification from H2O2-treated cells","pmids":["20364819"],"confidence":"High","gaps":["Identity of adaptor proteins mediating stress-dependent Km reduction was unknown","Whether similar kinetic regulation applies to other MAP3K–MKK6 pairs was untested"]},{"year":2012,"claim":"A second MKK6 crystal structure (non-phosphorylated, ATP-analogue-bound) revealed three unique activation-loop α-helices (AH1–AH3) that enforce autoinhibition by displacing αC-helix and sequestering the ATP γ-phosphate, establishing a distinct autoinhibitory mechanism from other MAP2Ks.","evidence":"X-ray crystallography at 2.6 Å, structural comparison with MAP2K1 and MAP2K4","pmids":["22383536"],"confidence":"High","gaps":["How upstream phosphorylation unfolds the AH1–AH3 helices was not resolved","No structure of MAP3K-bound MKK6 existed"]},{"year":2014,"claim":"Identification of FBXO31-mediated K48-linked polyubiquitination as a degradation pathway for MKK6 established ubiquitin-proteasome regulation as a mechanism controlling MKK6 protein levels during genotoxic stress.","evidence":"Co-IP, K48-specific ubiquitination assay, proteasome inhibitor rescue, functional assays in cancer cells","pmids":["24936062"],"confidence":"Medium","gaps":["Specific lysine residue(s) ubiquitinated by FBXO31 were not mapped","In vivo validation in knockout models was lacking"]},{"year":2017,"claim":"Mkk6 deletion in mice increased white adipose tissue thermogenesis and UCP1 expression, protecting against diet-induced obesity, revealing MKK6 as a negative regulator of adaptive thermogenesis—an unexpected role given its canonical p38-activating function.","evidence":"MKK6 knockout mice, metabolic phenotyping, UCP1 expression analysis, pathway dissection showing p38 activation via alternative AMPK–TAK–TAB pathway in WAT","pmids":["29021624"],"confidence":"High","gaps":["Whether MKK6's thermogenic suppression is cell-autonomous in adipocytes vs systemic was not fully resolved","Direct mechanism by which MKK6 suppresses UCP1 was not identified"]},{"year":2018,"claim":"Discovery that TRIM9s stabilizes MKK6 via K63-linked ubiquitination at Lys82, competing with degradative K48-linked ubiquitination at the same residue, while MKK6/p38 reciprocally stabilizes TRIM9s, revealed a positive feedback circuit controlling p38 pathway amplitude.","evidence":"Co-IP, K48 vs K63 linkage-specific ubiquitination assays, Lys82 mutagenesis, phospho-site mapping (Ser76/80) on TRIM9s","pmids":["29669288"],"confidence":"High","gaps":["Whether this feedback operates in all tissues or is context-specific was unknown","Other E3 ligases mediating K48 ubiquitination at Lys82 beyond FBXO31 were not identified"]},{"year":2020,"claim":"Optogenetic activation of MKK6 demonstrated that MKK6 inhibits ERK signaling with equal potency regardless of p38 inhibition, establishing a p38-independent cross-regulatory function of MKK6 between the p38 and ERK MAPK pathways.","evidence":"Light-activated (caged lysine) MKK6, pharmacological inhibition of all p38 isoforms, ERK phosphorylation readout, apoptosis assay","pmids":["32371393"],"confidence":"High","gaps":["Direct molecular target through which MKK6 inhibits ERK was not identified","Whether this cross-regulation occurs at a MAP3K, RAF, or MEK1/2 level was unknown"]},{"year":2021,"claim":"Identification of Gatad2b as a direct, p38-independent MKK6 substrate linked MKK6 kinase activity to chromatin remodeling (H3K9 acetylation, heterochromatin loosening) during somatic cell reprogramming, expanding MKK6's substrate repertoire beyond p38.","evidence":"Kinase assays, ATAC-seq, ChIP for H3K9ac, iPSC reprogramming efficiency with MKK6 overexpression/knockdown","pmids":["34815549"],"confidence":"Medium","gaps":["Phosphorylation sites on Gatad2b targeted by MKK6 were not fully mapped","Independent replication of Gatad2b as a direct substrate is needed"]},{"year":2022,"claim":"MKK6 deficiency in mice caused compensatory MKK3–p38γ/δ hyperactivation and mTOR-dependent cardiac hypertrophy reversible by rapamycin, revealing that the MKK6/MKK3 balance controls p38 isoform signaling output with pathological consequences for the heart.","evidence":"MKK6 knockout mice, longitudinal echocardiography, p38γ/δ double-knockout rescue, rapamycin treatment","pmids":["35971771"],"confidence":"High","gaps":["How MKK6 loss causes MKK3–p38γ/δ hyperactivation mechanistically was not determined","Whether cardiac hypertrophy depends on cardiomyocyte-autonomous MKK6 loss was not tested with conditional knockouts"]},{"year":2023,"claim":"The cryo-EM structure of the MKK6–p38α complex, combined with HDX-MS and MD simulations, revealed a dynamic multistep dual-phosphorylation mechanism and showed that MKK6's disordered N-terminus determines pathway specificity, providing the first high-resolution view of a MAP2K–MAPK catalytic complex.","evidence":"Cryo-EM, molecular dynamics simulation, hydrogen-deuterium exchange mass spectrometry, cell-based assays","pmids":["37708276"],"confidence":"High","gaps":["Structures of MKK6 complexed with p38β/γ/δ are not available","Mechanism by which the N-terminus discriminates p38 from ERK/JNK substrates at atomic resolution is incompletely resolved","No structure of an activated MAP3K–MKK6 complex exists"]},{"year":null,"claim":"Major unresolved questions include: the molecular target through which MKK6 inhibits ERK signaling independently of p38; whether MKK6's autoinhibitory dimer is disrupted by MAP3K binding or other mechanisms in cells; the full scope of non-p38 MKK6 substrates; and the structural basis for MKK6 vs MKK3 isoform selectivity toward p38 family members.","evidence":"","pmids":[],"confidence":"Medium","gaps":["Direct p38-independent MKK6 target in ERK pathway not identified","No MAP3K–MKK6 co-structure available","Comprehensive substrate profiling not performed"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[0,1,2,3,19,34,42,46]},{"term_id":"GO:0016740","term_label":"transferase activity","supporting_discovery_ids":[0,1,8,30]}],"localization":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[28,33]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,1,2,3,8,30,46]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[6,16,22,36]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[4,5,41]},{"term_id":"R-HSA-8953897","term_label":"Cellular responses to stimuli","supporting_discovery_ids":[11,17,30]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[10,26]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[24,42]}],"complexes":["ASK1 signalosome"],"partners":["MAPK14","MAPK12","MAPK11","MAP3K5","MAP3K3","TRIM9","FBXO31","RAC1"],"other_free_text":[]},"mechanistic_narrative":"MAP2K6 (MKK6) is a dual-specificity MAP kinase kinase that serves as the primary upstream activator of all four p38 MAPK isoforms (α, β, γ, δ), phosphorylating their TGY activation loop motif in response to diverse stresses, cytokines, and receptor signals relayed through MAP3Ks including MEKK3, ASK1, TAK1, TPL-2, and PKR [PMID:8621675, PMID:9430721, PMID:10347227, PMID:20364819, PMID:15229216, PMID:27402796]. Structural studies reveal that unphosphorylated MKK6 adopts an autoinhibited dimeric conformation with unique activation-loop α-helices that prevent premature activation, while the cryo-EM structure of the MKK6–p38α complex demonstrates a dynamic multistep dual-phosphorylation mechanism in which MKK6's disordered N-terminus determines pathway specificity [PMID:19141286, PMID:22383536, PMID:37708276]. MKK6 activity is negatively regulated by p38α-mediated destabilization of its own mRNA, FBXO31-directed K48-linked ubiquitination and proteasomal degradation, and PPM1G-catalyzed dephosphorylation, while TRIM9s-mediated K63-linked ubiquitination at Lys82 stabilizes MKK6 in a positive feedback loop [PMID:12482988, PMID:24936062, PMID:36349938, PMID:29669288]. Beyond canonical p38 signaling, MKK6 phosphorylates non-p38 substrates including Gatad2b to promote chromatin remodeling during somatic cell reprogramming, directly interacts with Rac1 to modulate GTPase activity, and exerts p38-independent inhibition of ERK signaling, underpinning its roles in inflammation, apoptosis, G2 arrest, thymocyte negative selection, adipogenesis, osteoclastogenesis, chondrogenesis, and cardiac homeostasis [PMID:34815549, PMID:17854274, PMID:32371393, PMID:12151339, PMID:10585441, PMID:35971771]."},"prefetch_data":{"uniprot":{"accession":"P52564","full_name":"Dual specificity mitogen-activated protein kinase kinase 6","aliases":["MAPK/ERK kinase 6","MEK 6","Stress-activated protein kinase kinase 3","SAPK kinase 3","SAPKK-3","SAPKK3"],"length_aa":334,"mass_kda":37.5,"function":"Dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. With MAP3K3/MKK3, catalyzes the concomitant phosphorylation of a threonine and a tyrosine residue in the MAP kinases p38 MAPK11, MAPK12, MAPK13 and MAPK14 and plays an important role in the regulation of cellular responses to cytokines and all kinds of stresses. Especially, MAP2K3/MKK3 and MAP2K6/MKK6 are both essential for the activation of MAPK11 and MAPK13 induced by environmental stress, whereas MAP2K6/MKK6 is the major MAPK11 activator in response to TNF. MAP2K6/MKK6 also phosphorylates and activates PAK6. The p38 MAP kinase signal transduction pathway leads to direct activation of transcription factors. Nuclear targets of p38 MAP kinase include the transcription factors ATF2 and ELK1. Within the p38 MAPK signal transduction pathway, MAP3K6/MKK6 mediates phosphorylation of STAT4 through MAPK14 activation, and is therefore required for STAT4 activation and STAT4-regulated gene expression in response to IL-12 stimulation. The pathway is also crucial for IL-6-induced SOCS3 expression and down-regulation of IL-6-mediated gene induction; and for IFNG-dependent gene transcription. Has a role in osteoclast differentiation through NF-kappa-B transactivation by TNFSF11, and in endochondral ossification and since SOX9 is another likely downstream target of the p38 MAPK pathway. MAP2K6/MKK6 mediates apoptotic cell death in thymocytes. Acts also as a regulator for melanocytes dendricity, through the modulation of Rho family GTPases","subcellular_location":"Nucleus; Cytoplasm; Cytoplasm, cytoskeleton","url":"https://www.uniprot.org/uniprotkb/P52564/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/MAP2K6","classification":"Not Classified","n_dependent_lines":2,"n_total_lines":1208,"dependency_fraction":0.0016556291390728477},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/MAP2K6","total_profiled":1310},"omim":[{"mim_id":"613199","title":"TAO KINASE 2; TAOK2","url":"https://www.omim.org/entry/613199"},{"mim_id":"611931","title":"PROTEIN PHOSPHATASE, MAGNESIUM/MANGANESE-DEPENDENT, 1L; PPM1L","url":"https://www.omim.org/entry/611931"},{"mim_id":"610660","title":"GLYOXYLATE REDUCTASE 1 HOMOLOG; GLYR1","url":"https://www.omim.org/entry/610660"},{"mim_id":"610266","title":"TAO KINASE 1; TAOK1","url":"https://www.omim.org/entry/610266"},{"mim_id":"609479","title":"MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 20; MAP3K20","url":"https://www.omim.org/entry/609479"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"intestine","ntpm":29.8},{"tissue":"skeletal muscle","ntpm":41.3}],"url":"https://www.proteinatlas.org/search/MAP2K6"},"hgnc":{"alias_symbol":["MEK6","MKK6","SAPKK3","MAPKK6","CRCMSL"],"prev_symbol":["PRKMK6"]},"alphafold":{"accession":"P52564","domains":[{"cath_id":"3.30.200.20","chopping":"35-129","consensus_level":"high","plddt":80.7797,"start":35,"end":129},{"cath_id":"1.10.510.10","chopping":"133-204_217-331","consensus_level":"high","plddt":91.7664,"start":133,"end":331}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P52564","model_url":"https://alphafold.ebi.ac.uk/files/AF-P52564-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P52564-F1-predicted_aligned_error_v6.png","plddt_mean":79.19},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=MAP2K6","jax_strain_url":"https://www.jax.org/strain/search?query=MAP2K6"},"sequence":{"accession":"P52564","fasta_url":"https://rest.uniprot.org/uniprotkb/P52564.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P52564/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P52564"}},"corpus_meta":[{"pmid":"8621675","id":"PMC_8621675","title":"Characterization of the structure and function of a novel MAP kinase kinase (MKK6).","date":"1996","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8621675","citation_count":477,"is_preprint":false},{"pmid":"9430721","id":"PMC_9430721","title":"Selective activation of p38 mitogen-activated protein (MAP) kinase isoforms by the MAP kinase kinases MKK3 and MKK6.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9430721","citation_count":477,"is_preprint":false},{"pmid":"9218798","id":"PMC_9218798","title":"Activation of the novel stress-activated protein kinase SAPK4 by cytokines and cellular stresses is mediated by SKK3 (MKK6); comparison of its substrate specificity with that of other SAP kinases.","date":"1997","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/9218798","citation_count":351,"is_preprint":false},{"pmid":"9029150","id":"PMC_9029150","title":"Activation of stress-activated protein kinase-3 (SAPK3) by cytokines and cellular stresses is mediated via SAPKK3 (MKK6); comparison of the specificities of SAPK3 and SAPK2 (RK/p38).","date":"1997","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/9029150","citation_count":327,"is_preprint":false},{"pmid":"10848581","id":"PMC_10848581","title":"Involvement of the MKK6-p38gamma cascade in gamma-radiation-induced cell cycle arrest.","date":"2000","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/10848581","citation_count":228,"is_preprint":false},{"pmid":"9712898","id":"PMC_9712898","title":"Tumor necrosis factor signaling to stress-activated protein kinase (SAPK)/Jun NH2-terminal kinase (JNK) and p38. Germinal center kinase couples TRAF2 to mitogen-activated protein kinase/ERK kinase kinase 1 and SAPK while receptor interacting protein associates with a mitogen-activated protein kinase kinase kinase upstream of MKK6 and p38.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9712898","citation_count":227,"is_preprint":false},{"pmid":"9525929","id":"PMC_9525929","title":"MKK6 activates myocardial cell NF-kappaB and inhibits apoptosis in a p38 mitogen-activated protein kinase-dependent manner.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9525929","citation_count":199,"is_preprint":false},{"pmid":"9575191","id":"PMC_9575191","title":"T lymphocyte activation signals for interleukin-2 production involve activation of MKK6-p38 and MKK7-SAPK/JNK signaling pathways sensitive to cyclosporin A.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9575191","citation_count":177,"is_preprint":false},{"pmid":"17964260","id":"PMC_17964260","title":"Functional interdependence at the chromatin level between the MKK6/p38 and IGF1/PI3K/AKT pathways during muscle differentiation.","date":"2007","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/17964260","citation_count":177,"is_preprint":false},{"pmid":"8626699","id":"PMC_8626699","title":"Cloning and characterization of MEK6, a novel member of the mitogen-activated protein kinase kinase cascade.","date":"1996","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8626699","citation_count":165,"is_preprint":false},{"pmid":"10816593","id":"PMC_10816593","title":"alpha B-crystallin gene induction and phosphorylation by MKK6-activated p38. A potential role for alpha B-crystallin as a target of the p38 branch of the cardiac stress response.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10816593","citation_count":138,"is_preprint":false},{"pmid":"9920834","id":"PMC_9920834","title":"The MKK6/p38 stress kinase cascade is critical for tumor necrosis factor-alpha-induced expression of monocyte-chemoattractant protein-1 in endothelial cells.","date":"1999","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/9920834","citation_count":138,"is_preprint":false},{"pmid":"9362518","id":"PMC_9362518","title":"Fas induces cytoplasmic apoptotic responses and activation of the MKK7-JNK/SAPK and MKK6-p38 pathways independent of CPP32-like proteases.","date":"1997","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/9362518","citation_count":136,"is_preprint":false},{"pmid":"20802223","id":"PMC_20802223","title":"HINKEL kinesin, ANP MAPKKKs and MKK6/ANQ MAPKK, which phosphorylates and activates MPK4 MAPK, constitute a pathway that is required for cytokinesis in Arabidopsis thaliana.","date":"2010","source":"Plant & cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/20802223","citation_count":133,"is_preprint":false},{"pmid":"16498455","id":"PMC_16498455","title":"Osteoclast differentiation requires TAK1 and MKK6 for NFATc1 induction and NF-kappaB transactivation by RANKL.","date":"2006","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/16498455","citation_count":128,"is_preprint":false},{"pmid":"11677259","id":"PMC_11677259","title":"Activation of MKK6, an upstream activator of p38, in Alzheimer's disease.","date":"2001","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11677259","citation_count":126,"is_preprint":false},{"pmid":"20004242","id":"PMC_20004242","title":"Differential activation of p38MAPK isoforms by MKK6 and MKK3.","date":"2009","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/20004242","citation_count":119,"is_preprint":false},{"pmid":"8861944","id":"PMC_8861944","title":"Purification and cDNA cloning of SAPKK3, the major activator of RK/p38 in stress- and cytokine-stimulated monocytes and epithelial cells.","date":"1996","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/8861944","citation_count":117,"is_preprint":false},{"pmid":"10961885","id":"PMC_10961885","title":"Importance of the MKK6/p38 pathway for interleukin-12-induced STAT4 serine phosphorylation and transcriptional activity.","date":"2000","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/10961885","citation_count":107,"is_preprint":false},{"pmid":"16489030","id":"PMC_16489030","title":"The p38 kinases MKK4 and MKK6 suppress metastatic colonization in human ovarian carcinoma.","date":"2006","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/16489030","citation_count":105,"is_preprint":false},{"pmid":"11279172","id":"PMC_11279172","title":"MKK6/3 and p38 MAPK pathway activation is not necessary for insulin-induced glucose uptake but regulates glucose transporter expression.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11279172","citation_count":104,"is_preprint":false},{"pmid":"10585441","id":"PMC_10585441","title":"Constitutively active mitogen-activated protein kinase kinase 6 (MKK6) or salicylate induces spontaneous 3T3-L1 adipogenesis.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10585441","citation_count":103,"is_preprint":false},{"pmid":"17016428","id":"PMC_17016428","title":"The role of the MKK6/p38 MAPK pathway in Wip1-dependent regulation of ErbB2-driven mammary gland tumorigenesis.","date":"2006","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/17016428","citation_count":92,"is_preprint":false},{"pmid":"17312125","id":"PMC_17312125","title":"Regulation of suppressor of cytokine signaling 3 (SOCS3) mRNA stability by TNF-alpha involves activation of the MKK6/p38MAPK/MK2 cascade.","date":"2007","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/17312125","citation_count":89,"is_preprint":false},{"pmid":"12151339","id":"PMC_12151339","title":"Differential involvement of p38 mitogen-activated protein kinase kinases MKK3 and MKK6 in T-cell apoptosis.","date":"2002","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/12151339","citation_count":89,"is_preprint":false},{"pmid":"29751559","id":"PMC_29751559","title":"Insights of Crosstalk between p53 Protein and the MKK3/MKK6/p38 MAPK Signaling Pathway in Cancer.","date":"2018","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/29751559","citation_count":88,"is_preprint":false},{"pmid":"16387856","id":"PMC_16387856","title":"Constitutive activation of MKK6 in chondrocytes of transgenic mice inhibits proliferation and delays endochondral bone formation.","date":"2005","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/16387856","citation_count":84,"is_preprint":false},{"pmid":"20067578","id":"PMC_20067578","title":"MKK6 binds and regulates expression of Parkinson's disease-related protein LRRK2.","date":"2010","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20067578","citation_count":83,"is_preprint":false},{"pmid":"10347227","id":"PMC_10347227","title":"MEK kinase 3 directly activates MKK6 and MKK7, specific activators of the p38 and c-Jun NH2-terminal kinases.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10347227","citation_count":83,"is_preprint":false},{"pmid":"16342939","id":"PMC_16342939","title":"Prevention of MKK6-dependent activation by binding to p38alpha MAP kinase.","date":"2005","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16342939","citation_count":80,"is_preprint":false},{"pmid":"15229216","id":"PMC_15229216","title":"Protein kinase R (PKR) interacts with and activates mitogen-activated protein kinase kinase 6 (MKK6) in response to double-stranded RNA stimulation.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15229216","citation_count":79,"is_preprint":false},{"pmid":"27526785","id":"PMC_27526785","title":"miR-625-3p regulates oxaliplatin resistance by targeting MAP2K6-p38 signalling in human colorectal adenocarcinoma cells.","date":"2016","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/27526785","citation_count":77,"is_preprint":false},{"pmid":"12482988","id":"PMC_12482988","title":"Negative feedback regulation of MKK6 mRNA stability by p38alpha mitogen-activated protein kinase.","date":"2003","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/12482988","citation_count":70,"is_preprint":false},{"pmid":"22488549","id":"PMC_22488549","title":"Antiinflammatory functions of p38 in mouse models of rheumatoid arthritis: advantages of targeting upstream kinases MKK-3 or MKK-6.","date":"2012","source":"Arthritis and rheumatism","url":"https://pubmed.ncbi.nlm.nih.gov/22488549","citation_count":66,"is_preprint":false},{"pmid":"34709743","id":"PMC_34709743","title":"A novel tumour suppressor protein encoded by circMAPK14 inhibits progression and metastasis of colorectal cancer by competitively binding to MKK6.","date":"2021","source":"Clinical and translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/34709743","citation_count":58,"is_preprint":false},{"pmid":"20445555","id":"PMC_20445555","title":"PKC-delta and -eta, MEKK-1, MEK-6, MEK-3, and p38-delta are essential mediators of the response of normal human epidermal keratinocytes to differentiating agents.","date":"2010","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/20445555","citation_count":58,"is_preprint":false},{"pmid":"29021624","id":"PMC_29021624","title":"MKK6 controls T3-mediated browning of white adipose tissue.","date":"2017","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/29021624","citation_count":57,"is_preprint":false},{"pmid":"27402796","id":"PMC_27402796","title":"TLR and TNF-R1 activation of the MKK3/MKK6-p38α axis in macrophages is mediated by TPL-2 kinase.","date":"2016","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/27402796","citation_count":52,"is_preprint":false},{"pmid":"17577251","id":"PMC_17577251","title":"Up-regulation of MKK4, MKK6 and MKK7 during prostate cancer progression: an important role for SAPK signalling in prostatic neoplasia.","date":"2007","source":"The Journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/17577251","citation_count":51,"is_preprint":false},{"pmid":"30575817","id":"PMC_30575817","title":"Long noncoding RNA CRCMSL suppresses tumor invasive and metastasis in colorectal carcinoma through nucleocytoplasmic shuttling of HMGB2.","date":"2018","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/30575817","citation_count":47,"is_preprint":false},{"pmid":"16000313","id":"PMC_16000313","title":"15S-Lipoxygenase-2 mediates arachidonic acid-stimulated adhesion of human breast carcinoma cells through the activation of TAK1, MKK6, and p38 MAPK.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16000313","citation_count":47,"is_preprint":false},{"pmid":"24936062","id":"PMC_24936062","title":"F-box only protein 31 (FBXO31) negatively regulates p38 mitogen-activated protein kinase (MAPK) signaling by mediating lysine 48-linked ubiquitination and degradation of mitogen-activated protein kinase kinase 6 (MKK6).","date":"2014","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24936062","citation_count":47,"is_preprint":false},{"pmid":"21132268","id":"PMC_21132268","title":"ß-Elemene inhibits proliferation of human glioblastoma cells and causes cell-cycle G0/G1 arrest via mutually compensatory activation of MKK3 and MKK6.","date":"2010","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/21132268","citation_count":45,"is_preprint":false},{"pmid":"31216469","id":"PMC_31216469","title":"Induction of Pluripotent Stem Cells from Mouse Embryonic Fibroblasts by Jdp2-Jhdm1b-Mkk6-Glis1-Nanog-Essrb-Sall4.","date":"2019","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/31216469","citation_count":43,"is_preprint":false},{"pmid":"29229918","id":"PMC_29229918","title":"Negative regulation of TGF-β1-induced MKK6-p38 and MEK-ERK signalling and epithelial-mesenchymal transition by Rac1b.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/29229918","citation_count":42,"is_preprint":false},{"pmid":"30391783","id":"PMC_30391783","title":"Gossypetin is a novel MKK3 and MKK6 inhibitor that suppresses esophageal cancer growth in vitro and in vivo.","date":"2018","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/30391783","citation_count":39,"is_preprint":false},{"pmid":"30185442","id":"PMC_30185442","title":"MKK6 Functions in Two Parallel MAP Kinase Cascades in Immune Signaling.","date":"2018","source":"Plant physiology","url":"https://pubmed.ncbi.nlm.nih.gov/30185442","citation_count":37,"is_preprint":false},{"pmid":"25214442","id":"PMC_25214442","title":"Monocytic cell differentiation from band-stage neutrophils under inflammatory conditions via MKK6 activation.","date":"2014","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/25214442","citation_count":36,"is_preprint":false},{"pmid":"11304531","id":"PMC_11304531","title":"Parallel regulation of mitogen-activated protein kinase kinase 3 (MKK3) and MKK6 in Gq-signaling cascade.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11304531","citation_count":36,"is_preprint":false},{"pmid":"33372369","id":"PMC_33372369","title":"CircASPH promotes KGN cells proliferation through miR-375/MAP2K6 axis in Polycystic Ovary Syndrome.","date":"2020","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/33372369","citation_count":35,"is_preprint":false},{"pmid":"31698040","id":"PMC_31698040","title":"Circ_016719 plays a critical role in neuron cell apoptosis induced by I/R via targeting miR-29c/Map2k6.","date":"2019","source":"Molecular and cellular probes","url":"https://pubmed.ncbi.nlm.nih.gov/31698040","citation_count":35,"is_preprint":false},{"pmid":"17007737","id":"PMC_17007737","title":"Effects of sodium ferulate on amyloid-beta-induced MKK3/MKK6-p38 MAPK-Hsp27 signal pathway and apoptosis in rat hippocampus.","date":"2006","source":"Acta pharmacologica Sinica","url":"https://pubmed.ncbi.nlm.nih.gov/17007737","citation_count":35,"is_preprint":false},{"pmid":"15644321","id":"PMC_15644321","title":"Activation of mitogen-activated protein kinase kinase (MKK) 3 and MKK6 by type I interferons.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15644321","citation_count":35,"is_preprint":false},{"pmid":"33051781","id":"PMC_33051781","title":"Quercetin inhibits caerulein-induced acute pancreatitis through regulating miR-216b by targeting MAP2K6 and NEAT1.","date":"2020","source":"Inflammopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/33051781","citation_count":34,"is_preprint":false},{"pmid":"22164285","id":"PMC_22164285","title":"Balance between MKK6 and MKK3 mediates p38 MAPK associated resistance to cisplatin in NSCLC.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22164285","citation_count":34,"is_preprint":false},{"pmid":"18327563","id":"PMC_18327563","title":"ASK1 and MAP2K6 as modifiers of age at onset in Huntington's disease.","date":"2008","source":"Journal of molecular medicine (Berlin, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/18327563","citation_count":33,"is_preprint":false},{"pmid":"31794094","id":"PMC_31794094","title":"Scaffold protein GhMORG1 enhances the resistance of cotton to Fusarium oxysporum by facilitating the MKK6-MPK4 cascade.","date":"2019","source":"Plant biotechnology journal","url":"https://pubmed.ncbi.nlm.nih.gov/31794094","citation_count":33,"is_preprint":false},{"pmid":"37708276","id":"PMC_37708276","title":"Architecture of the MKK6-p38α complex defines the basis of MAPK specificity and activation.","date":"2023","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/37708276","citation_count":32,"is_preprint":false},{"pmid":"35192930","id":"PMC_35192930","title":"MiR-1298-5p level downregulation induced by Helicobacter pylori infection inhibits autophagy and promotes gastric cancer development by targeting MAP2K6.","date":"2022","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/35192930","citation_count":31,"is_preprint":false},{"pmid":"19141286","id":"PMC_19141286","title":"The structure of the MAP2K MEK6 reveals an autoinhibitory dimer.","date":"2009","source":"Structure (London, England : 1993)","url":"https://pubmed.ncbi.nlm.nih.gov/19141286","citation_count":30,"is_preprint":false},{"pmid":"17301822","id":"PMC_17301822","title":"Tissue inhibitor of metalloproteinase-1 promotes hematopoietic differentiation via caspase-3 upstream the MEKK1/MEK6/p38alpha pathway.","date":"2007","source":"Leukemia","url":"https://pubmed.ncbi.nlm.nih.gov/17301822","citation_count":29,"is_preprint":false},{"pmid":"26745320","id":"PMC_26745320","title":"MKK6 from pacific white shrimp Litopenaeus vannamei is responsive to bacterial and WSSV infection.","date":"2015","source":"Molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/26745320","citation_count":29,"is_preprint":false},{"pmid":"10880959","id":"PMC_10880959","title":"Identification of a nuclear export signal in MKK6, an activator of the carp p38 mitogen-activated protein kinases.","date":"2000","source":"European journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10880959","citation_count":29,"is_preprint":false},{"pmid":"29669288","id":"PMC_29669288","title":"Mutual Stabilization between TRIM9 Short Isoform and MKK6 Potentiates p38 Signaling to Synergistically Suppress Glioblastoma Progression.","date":"2018","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/29669288","citation_count":29,"is_preprint":false},{"pmid":"16960152","id":"PMC_16960152","title":"Human Langerhans-cell activation triggered in vitro by conditionally expressed MKK6 is counterregulated by the downstream effector RelB.","date":"2006","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/16960152","citation_count":29,"is_preprint":false},{"pmid":"24400116","id":"PMC_24400116","title":"Differential roles of MAPK kinases MKK3 and MKK6 in osteoclastogenesis and bone loss.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24400116","citation_count":28,"is_preprint":false},{"pmid":"12829175","id":"PMC_12829175","title":"The MKK6-p38 MAPK pathway prolongs the cardiac contractile calcium transient, downregulates SERCA2, and activates NF-AT.","date":"2003","source":"Cardiovascular research","url":"https://pubmed.ncbi.nlm.nih.gov/12829175","citation_count":28,"is_preprint":false},{"pmid":"28811647","id":"PMC_28811647","title":"Biogenesis of Pro-senescent Microparticles by Endothelial Colony Forming Cells from Premature Neonates is driven by SIRT1-Dependent Epigenetic Regulation of MKK6.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28811647","citation_count":28,"is_preprint":false},{"pmid":"30102978","id":"PMC_30102978","title":"Pharmacological targeting of p38 MAP-Kinase 6 (MAP2K6) inhibits the growth of esophageal adenocarcinoma.","date":"2018","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/30102978","citation_count":27,"is_preprint":false},{"pmid":"21308746","id":"PMC_21308746","title":"Role of C/EBP-β, p38 MAPK, and MKK6 in IL-1β-mediated C3 gene regulation in astrocytes.","date":"2011","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21308746","citation_count":27,"is_preprint":false},{"pmid":"27181679","id":"PMC_27181679","title":"MEK2 controls the activation of MKK3/MKK6-p38 axis involved in the MDA-MB-231 breast cancer cell survival: Correlation with cyclin D1 expression.","date":"2016","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/27181679","citation_count":26,"is_preprint":false},{"pmid":"35971771","id":"PMC_35971771","title":"MKK6 deficiency promotes cardiac dysfunction through MKK3-p38γ/δ-mTOR hyperactivation.","date":"2022","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/35971771","citation_count":25,"is_preprint":false},{"pmid":"22383536","id":"PMC_22383536","title":"Crystal structure of non-phosphorylated MAP2K6 in a putative auto-inhibition state.","date":"2012","source":"Journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22383536","citation_count":24,"is_preprint":false},{"pmid":"24085465","id":"PMC_24085465","title":"β-Amyloid-evoked apoptotic cell death is mediated through MKK6-p66shc pathway.","date":"2013","source":"Neuromolecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/24085465","citation_count":23,"is_preprint":false},{"pmid":"17983595","id":"PMC_17983595","title":"MKK6-p38 MAPK signaling pathway enhances survival but not bone-resorbing activity of osteoclasts.","date":"2007","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/17983595","citation_count":23,"is_preprint":false},{"pmid":"25019214","id":"PMC_25019214","title":"MKK6 is upregulated in human esophageal, stomach, and colon cancers.","date":"2014","source":"Cancer investigation","url":"https://pubmed.ncbi.nlm.nih.gov/25019214","citation_count":20,"is_preprint":false},{"pmid":"29566993","id":"PMC_29566993","title":"MiR-422a targets MAPKK6 and regulates cell growth and apoptosis in colorectal cancer cells.","date":"2018","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/29566993","citation_count":19,"is_preprint":false},{"pmid":"27009039","id":"PMC_27009039","title":"Genetic Analyses Reveal Functions for MAP2K3 and MAP2K6 in Mouse Testis Determination.","date":"2016","source":"Biology of reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/27009039","citation_count":18,"is_preprint":false},{"pmid":"32371393","id":"PMC_32371393","title":"Optical control of MAP kinase kinase 6 (MKK6) reveals that it has divergent roles in pro-apoptotic and anti-proliferative signaling.","date":"2020","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/32371393","citation_count":18,"is_preprint":false},{"pmid":"20869211","id":"PMC_20869211","title":"MKK6 increases the melanocyte dendricity through the regulation of Rho family GTPases.","date":"2010","source":"Journal of dermatological science","url":"https://pubmed.ncbi.nlm.nih.gov/20869211","citation_count":18,"is_preprint":false},{"pmid":"30245131","id":"PMC_30245131","title":"Quantitative proteome analysis identifies MAP2K6 as potential regulator of LIFR-induced radioresistance in nasopharyngeal carcinoma cells.","date":"2018","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/30245131","citation_count":17,"is_preprint":false},{"pmid":"33554397","id":"PMC_33554397","title":"The interaction of p38 with its upstream kinase MKK6.","date":"2021","source":"Protein science : a publication of the Protein Society","url":"https://pubmed.ncbi.nlm.nih.gov/33554397","citation_count":16,"is_preprint":false},{"pmid":"32582987","id":"PMC_32582987","title":"MicroRNA‑375 prevents TGF‑β‑dependent transdifferentiation of lung fibroblasts via the MAP2K6/P38 pathway.","date":"2020","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/32582987","citation_count":15,"is_preprint":false},{"pmid":"33128541","id":"PMC_33128541","title":"Elevated miR-10a-5p facilitates cell cycle and restrains adipogenic differentiation via targeting Map2k6 and Fasn, respectively.","date":"2020","source":"Acta biochimica et biophysica Sinica","url":"https://pubmed.ncbi.nlm.nih.gov/33128541","citation_count":15,"is_preprint":false},{"pmid":"37368704","id":"PMC_37368704","title":"Microcystin-LR-Exposure-Induced Kidney Damage by Inhibiting MKK6-Mediated Mitophagy in Mice.","date":"2023","source":"Toxins","url":"https://pubmed.ncbi.nlm.nih.gov/37368704","citation_count":14,"is_preprint":false},{"pmid":"25111695","id":"PMC_25111695","title":"Involvement of potato (Solanum tuberosum L.) MKK6 in response to potato virus Y.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25111695","citation_count":14,"is_preprint":false},{"pmid":"20364819","id":"PMC_20364819","title":"Mechanism of oxidative stress-induced ASK1-catalyzed MKK6 phosphorylation.","date":"2010","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20364819","citation_count":14,"is_preprint":false},{"pmid":"34581623","id":"PMC_34581623","title":"CircRNA-MSR Regulates LPS-Induced C28/I2 Chondrocyte Injury through miR-643/MAP2K6 Signaling Pathway.","date":"2021","source":"Cartilage","url":"https://pubmed.ncbi.nlm.nih.gov/34581623","citation_count":11,"is_preprint":false},{"pmid":"38787149","id":"PMC_38787149","title":"Inhibitory Impact of Prenatal Exposure to Nano-Polystyrene Particles on the MAP2K6/p38 MAPK Axis Inducing Embryonic Developmental Abnormalities in Mice.","date":"2024","source":"Toxics","url":"https://pubmed.ncbi.nlm.nih.gov/38787149","citation_count":11,"is_preprint":false},{"pmid":"28604448","id":"PMC_28604448","title":"MAP2K6-FP Enhances the Sensitiveness of Paclitaxel for Ovarian Cancer via Inducing Autophagy.","date":"2017","source":"International journal of gynecological cancer : official journal of the International Gynecological Cancer Society","url":"https://pubmed.ncbi.nlm.nih.gov/28604448","citation_count":11,"is_preprint":false},{"pmid":"34815549","id":"PMC_34815549","title":"MAP2K6 remodels chromatin and facilitates reprogramming by activating Gatad2b-phosphorylation dependent heterochromatin loosening.","date":"2021","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/34815549","citation_count":10,"is_preprint":false},{"pmid":"26059046","id":"PMC_26059046","title":"A de novo 1.58 Mb deletion, including MAP2K6 and mapping 1.28 Mb upstream to SOX9, identified in a patient with Pierre Robin sequence and osteopenia with multiple fractures.","date":"2015","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/26059046","citation_count":10,"is_preprint":false},{"pmid":"35689709","id":"PMC_35689709","title":"Circ_0005925 Promotes Granulosa Cell Growth by Targeting MiR-324-3p to Upregulate MAP2K6 in Polycystic Ovary Syndrome.","date":"2022","source":"Biochemical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/35689709","citation_count":9,"is_preprint":false},{"pmid":"22454693","id":"PMC_22454693","title":"Catenarin Prevents Type 1 Diabetes in Nonobese Diabetic Mice via Inhibition of Leukocyte Migration Involving the MEK6/p38 and MEK7/JNK Pathways.","date":"2012","source":"Evidence-based complementary and alternative medicine : eCAM","url":"https://pubmed.ncbi.nlm.nih.gov/22454693","citation_count":9,"is_preprint":false},{"pmid":"20162623","id":"PMC_20162623","title":"Activin A induction of erythroid differentiation through MKK6-p38alpha/p38beta pathway is inhibited by follistatin.","date":"2010","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/20162623","citation_count":9,"is_preprint":false},{"pmid":"21544193","id":"PMC_21544193","title":"A novel DC therapy with manipulation of MKK6 gene on nickel allergy in mice.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21544193","citation_count":9,"is_preprint":false},{"pmid":"17854274","id":"PMC_17854274","title":"MKK6 phosphorylation regulates production of superoxide by enhancing Rac GTPase activity.","date":"2007","source":"Antioxidants & redox signaling","url":"https://pubmed.ncbi.nlm.nih.gov/17854274","citation_count":9,"is_preprint":false},{"pmid":"36205565","id":"PMC_36205565","title":"APEX1 promotes the oncogenicity of hepatocellular carcinoma via regulation of MAP2K6.","date":"2022","source":"Aging","url":"https://pubmed.ncbi.nlm.nih.gov/36205565","citation_count":8,"is_preprint":false},{"pmid":"34948353","id":"PMC_34948353","title":"MEK6 Overexpression Exacerbates Fat Accumulation and Inflammatory Cytokines in High-Fat Diet-Induced Obesity.","date":"2021","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/34948353","citation_count":8,"is_preprint":false},{"pmid":"36349938","id":"PMC_36349938","title":"PPM1G promotes the progression of lung adenocarcinoma by inhibiting p38 activation via dephosphorylation of MEK6.","date":"2023","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/36349938","citation_count":8,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":52124,"output_tokens":10486,"usd":0.156831},"stage2":{"model":"claude-opus-4-6","input_tokens":14735,"output_tokens":5403,"usd":0.313125},"total_usd":0.469956,"stage1_batch_id":"msgbatch_01Mgbec4vM6c9vXht7JVJzss","stage2_batch_id":"msgbatch_01JkuuH5RB2BdJNsgnhjbC6s","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1996,\n      \"finding\": \"MKK6 (MAP2K6) was identified as a novel MAP kinase kinase that selectively phosphorylates and activates p38 MAPK, but not ERK or JNK family members, as demonstrated by direct kinase assays and co-transfection studies. Two human splice isoforms (278 and 334 aa) and one murine isoform were cloned.\",\n      \"method\": \"cDNA cloning, co-transfection assays, direct in vitro kinase assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro kinase assay with multiple isoforms, replicated by multiple labs\",\n      \"pmids\": [\"8621675\", \"8626699\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"SAPKK3/MKK6 was purified from rabbit skeletal muscle as the major activator of RK/p38 in stress- and cytokine-stimulated monocytes and epithelial cells; it activates p38 but not JNK/SAPK in vitro.\",\n      \"method\": \"Protein purification to near homogeneity, tryptic peptide sequencing, cDNA cloning, in vitro kinase assay\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — biochemical purification combined with in vitro reconstitution\",\n      \"pmids\": [\"8861944\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"MKK6 (SAPKK3) selectively activates SAPK3/p38gamma and SAPK4/p38delta in response to cytokines and cellular stresses, and is the only activator of these isoforms induced by IL-1 or stress in KB cells. MKK6 mediates phosphorylation of ATF2, Elk-1 and SAP-1 through these downstream kinases.\",\n      \"method\": \"In vitro kinase assay, co-transfection in COS cells, immunoprecipitation kinase assay\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution replicated in two independent papers\",\n      \"pmids\": [\"9029150\", \"9218798\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"MKK6 is identified as a common activator of p38α, p38β2, and p38γ isoforms, while MKK3 activates only p38α and p38γ, defining selective coupling between upstream kinases and p38 isoforms.\",\n      \"method\": \"Molecular cloning, co-transfection assays, in vitro kinase assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — replicated across multiple labs with direct kinase assays\",\n      \"pmids\": [\"9430721\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"In Fas signaling, MKK6 is the major upstream activator of p38, acting independently of CPP32-like proteases; MKK7 (not MKK4/SEK1) activates JNK in the same pathway, establishing pathway-specific MKK usage downstream of Fas.\",\n      \"method\": \"Immunoprecipitation kinase assay, peptide inhibitor experiments, co-transfection\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal pathway dissection with specific inhibitors, single lab\",\n      \"pmids\": [\"9362518\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"MKK6 (constitutively active MKK6(Glu)) selectively activates p38 in cardiac myocytes, protecting them from apoptosis in a p38-dependent manner and activating NF-κB transcription; anti-apoptotic effect is blocked by SB203580.\",\n      \"method\": \"Overexpression of constitutively active MKK6(Glu) in primary neonatal rat ventricular myocytes, SB203580 inhibition, NF-κB reporter assay, cell death assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean gain-of-function with pharmacological validation and specific cellular phenotype\",\n      \"pmids\": [\"9525929\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"MKK6 is activated by T cell receptor signaling and is required for p38-dependent IL-2 promoter transcriptional activation; dominant-negative MKK6 suppresses IL-2 promoter activity; both MKK6-p38 and MKK7-JNK pathways are inhibited by cyclosporin A.\",\n      \"method\": \"Dominant-negative mutant expression, luciferase reporter assay, kinase assay in T lymphocytes\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — dominant-negative approach with reporter assay, single lab\",\n      \"pmids\": [\"9575191\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"In TNF signaling, RIP (receptor interacting protein) associates with an endogenous MAPKKK that activates MKK6 and the p38 pathway in vitro; TRAF2 activation of p38 requires RIP, placing RIP upstream of MKK6.\",\n      \"method\": \"In vivo binding assays, in vitro kinase cascade assay, co-expression studies\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vitro pathway reconstitution, single lab\",\n      \"pmids\": [\"9712898\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"MEKK3 (and MEKK2) directly phosphorylate and activate MKK6 in vitro, identifying MEKK3 as a MAP3K upstream of MKK6 in the p38 pathway; immunoprecipitated MEKK3 directly activated recombinant MKK6 in cell-free assays.\",\n      \"method\": \"Co-expression in COS-7 cells, in vitro kinase assay with immunoprecipitated MEKK3/MKK6, MAPKAPK2 phosphorylation assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct in vitro reconstitution of upstream→MKK6 phosphorylation\",\n      \"pmids\": [\"10347227\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"The MKK6/p38 pathway is required for TNF-α-induced MCP-1 expression in endothelial cells; dominant-negative MKK6 strongly inhibits MCP-1, and constitutively active MKK6 enhances it, as shown by flow cytometry, Northern blot, and luciferase reporter assays.\",\n      \"method\": \"Dominant-negative and constitutively active MKK6 expression, flow cytometry, Northern blot, luciferase reporter assay\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods, single lab\",\n      \"pmids\": [\"9920834\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Constitutively active MKK6 (MKK6(Glu)) is sufficient to drive spontaneous adipogenesis of 3T3-L1 fibroblasts in the absence of hormonal inducers, demonstrating that p38 activation via MKK6 is sufficient for the adipogenic differentiation program.\",\n      \"method\": \"Inducible expression system for MKK6(Glu), Oil Red O staining, morphological analysis in 3T3-L1 and NIH-3T3 cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean gain-of-function with specific differentiation phenotype, single lab\",\n      \"pmids\": [\"10585441\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Activation of the MKK6-p38γ cascade, but not other p38 isoforms, is required and sufficient for γ-irradiation-induced G2 cell cycle arrest; dominant-negative MKK6 or p38γ abrogates the DNA damage-induced G2 delay; MKK6 activation is ATM-dependent and leads to Cds1/Chk2 activation.\",\n      \"method\": \"Dominant-negative allele expression, gamma-irradiation, cell cycle analysis, epistasis with ATM\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis with specific isoform selectivity and defined signaling cascade, replicated with multiple dominant-negative alleles\",\n      \"pmids\": [\"10848581\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"MKK6(Glu) induces p38-dependent transcriptional upregulation and phosphorylation of αB-crystallin on serine-59 (via MAPKAP-K2) in cardiac myocytes, providing cytoprotection against stress-induced apoptosis.\",\n      \"method\": \"Constitutively active MKK6(Glu) overexpression, Northern/Western blot, in vitro kinase assay, apoptosis assay in cardiac myocytes\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple assay types, defined downstream phosphorylation site identified\",\n      \"pmids\": [\"10816593\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"IL-12 activates p38 which, together with MKK6, phosphorylates STAT4 on serine 721 to drive full STAT4 transcriptional activity; mutation of Ser721 abrogates IL-12-induced transcription, establishing an MKK6/p38α/STAT4 signaling axis.\",\n      \"method\": \"Co-transfection, in vitro kinase assay, site-directed mutagenesis (S721A), luciferase reporter, dominant-negative MKK6\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro phosphorylation, site-directed mutagenesis, and functional reporter assay\",\n      \"pmids\": [\"10961885\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"G protein Gαq activates MKK6 in a Rho-dependent manner, while Gβγ activates MKK6 via Rho-, Rac-, and Cdc42-dependent pathways; kinase-deficient MKK6 blocks p38 activation by Gαq and Gβγ, placing MKK6 downstream of Gq-coupled receptors.\",\n      \"method\": \"Kinase-deficient mutant expression in HEK293 cells, p38 activity assay, GTPase dependency studies\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — epistasis with dominant-negative mutants, single lab\",\n      \"pmids\": [\"11304531\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"MKK6/MKK3-p38 MAPK pathway activation by constitutively active MKK6 upregulates GLUT1 and downregulates GLUT4 expression in adipocytes and myotubes, increasing basal glucose transport while reducing insulin-stimulated uptake; p38 activation is not required for insulin-induced glucose uptake itself.\",\n      \"method\": \"Adenovirus-mediated expression of constitutively active/dominant-negative MKK6 and MKK3, glucose uptake assay, Western blot in 3T3-L1 adipocytes and L6 myotubes\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — orthogonal gain- and loss-of-function, multiple cell types\",\n      \"pmids\": [\"11279172\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"MKK6 is specifically required for deletion of double-positive thymocytes in vivo (negative selection), while MKK3 (not MKK6) is required for activation-induced cell death and cytokine withdrawal-induced apoptosis of peripheral CD4+ T cells; established using Mkk6-/- and Mkk3-/- mice.\",\n      \"method\": \"Mkk6 knockout mouse generation, thymocyte deletion assay, T cell apoptosis assays\",\n      \"journal\": \"EMBO reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean knockout mouse with specific and distinct in vivo phenotype\",\n      \"pmids\": [\"12151339\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"p38α negatively regulates MKK6 mRNA stability via the 3'UTR of MKK6 mRNA, forming a negative feedback loop; p38α-/- cells have elevated MKK6 mRNA and protein; reintroduction of p38α normalizes MKK6 levels.\",\n      \"method\": \"p38α knockout MEFs, pharmacological p38α inhibition, mRNA stability assay, 3'UTR reporter assay\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — knockout cells + rescue experiment + 3'UTR reporter, multiple orthogonal methods\",\n      \"pmids\": [\"12482988\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"MKK6-p38 MAPK pathway activation prolongs cardiac contractile calcium transients by downregulating SERCA2 expression, increasing diastolic [Ca2+]i and activating NF-AT; SERCA2 overexpression reverses these effects.\",\n      \"method\": \"MKK6(Glu) overexpression in neonatal rat ventricular myocytes, indo-1 calcium imaging, Northern/Western blot, SERCA2 reporter assay, NF-AT reporter\",\n      \"journal\": \"Cardiovascular research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods, single lab with rescue experiment\",\n      \"pmids\": [\"12829175\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"PKR (double-stranded RNA-activated protein kinase) interacts with and directly phosphorylates MKK6 (but not MKK3 or MKK4) following dsRNA stimulation, providing a mechanism for p38 activation in the dsRNA response.\",\n      \"method\": \"Co-immunoprecipitation, in vitro kinase assay, coupled kinase assay, kinase-inactive PKR dominant-negative, PKR-null cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro phosphorylation reconstitution + genetic validation with KI mutant\",\n      \"pmids\": [\"15229216\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"MEKK3 activates MKK6 and p38 in the p38 pathway in intact cells; anisomycin, sorbitol, or MEKK3 expression all activate MAPKAPK2 in a p38/SB203580-sensitive manner, confirming MEKK3→MKK6→p38 as a physiologically relevant cascade.\",\n      \"method\": \"Co-expression in COS-7 and HEK293 cells, in vitro kinase assay, SB203580 inhibition\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vitro assay confirmed in intact cells with pharmacological validation\",\n      \"pmids\": [\"10347227\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Selectivity pocket inhibitors of p38α (e.g., BIRB796) that stabilize a DFG-out conformation prevent MKK6-dependent phosphorylation/activation of p38α, while purine-site-only inhibitors do not; crystal structures of seven inhibitor complexes were solved, showing the activation loop displacement that blocks MKK6 recognition.\",\n      \"method\": \"Kinetic analysis, novel cell-free MKK6-dependent p38α activation assay, crystal structures (4 new), cellular TNFα inhibition assay\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structures combined with in vitro mechanistic assay\",\n      \"pmids\": [\"16342939\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Type I interferons (IFNα/β) activate both MKK3 and MKK6, which are required for downstream p38 activation and for IFN-dependent gene transcription (Isg15, Irf-9) via a STAT-independent mechanism, as shown using MKK3-/-/MKK6-/- double-knockout MEFs.\",\n      \"method\": \"Double-knockout MEFs, luciferase reporter assay, kinase assay, qPCR\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — double-knockout genetic model with multiple functional readouts\",\n      \"pmids\": [\"15644321\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"TAK1 and MKK6 (but not MKK3) are required for RANKL-induced NFATc1 induction and NF-κB transactivation (via p65 Ser-536 phosphorylation) during osteoclast differentiation; dominant-negative TAK1 and MKK6 both impair osteoclastogenesis.\",\n      \"method\": \"Retroviral transduction of dominant-negative kinases, RANKL-stimulated primary bone marrow cells, NFATc1 and NF-κB reporter assays, Western blot\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — dominant-negative epistasis with primary cells and multiple readouts, single lab\",\n      \"pmids\": [\"16498455\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"MKK6-p38 signaling in inflammation-activated muscle progenitors recruits the SWI/SNF chromatin-remodeling complex to muscle gene promoters; MKK6/p38 and IGF1/PI3K/AKT pathways converge on chromatin of muscle genes to regulate distinct components of the myogenic transcriptosome.\",\n      \"method\": \"Chromatin immunoprecipitation, genetic and pharmacological inhibition of p38 and AKT, MEF2-SWI/SNF complex assembly assays\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — ChIP-based mechanistic dissection with multiple genetic perturbations\",\n      \"pmids\": [\"17964260\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"TNF-α stabilizes SOCS3 mRNA via activation of the MKK6/p38MAPK/MK2 cascade; in MK2-deficient fibroblasts and macrophages, basal SOCS3 expression is reduced and TNF-α-induced SOCS3 mRNA stabilization is impaired. The 3'UTR AUUUA/U-rich region (positions 2422–2541) of SOCS3 is identified as the regulatory target.\",\n      \"method\": \"MK2 knockout cells, mRNA stability assay, 3'UTR mapping, dominant-negative MKK6 expression\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — knockout validation + 3'UTR mapping + multiple cell types\",\n      \"pmids\": [\"17312125\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Constitutively active MKK6 in chondrocytes in vivo (transgenic mice) reduces chondrocyte proliferation, inhibits hypertrophic differentiation, delays ossification, and increases Sox9 transcriptional activity; p38 signaling increases Sox9 transactivation in transfected cells, suggesting Sox9 is a downstream target of MKK6-p38 in endochondral ossification.\",\n      \"method\": \"Transgenic mouse generation, in situ hybridization, histology, co-transfection reporter assay for Sox9\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo transgenic gain-of-function with mechanistic in vitro follow-up\",\n      \"pmids\": [\"16387856\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"MKK6 phosphorylation (especially Tyr219) enhances Rac GTPase activity; constitutively active MKK6 directly interacts with Rac1 in vitro and inhibits PMA-induced NADPH oxidase activation in RAW cells; MKK6 deficiency leads to increased Rac1-GTP levels in brain tissue.\",\n      \"method\": \"Co-immunoprecipitation under redox stress, in vitro kinase assay, site-directed mutagenesis (Y219F), NADPH oxidase activity assay, MKK6 knockout brain tissue\",\n      \"journal\": \"Antioxidants & redox signaling\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vitro binding + mutagenesis + knockout validation\",\n      \"pmids\": [\"17854274\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"The crystal structure of the MEK6/MAP2K6 kinase domain (phosphomimetic DD mutant, 2.3 Å) reveals an autoinhibited elongated dimer; the interface includes the phosphate-binding ribbon, activation loop, and an arginine stack; the dimer conformation prevents activation loop phosphorylation by inappropriate kinases. Solution SAXS confirms the dimer.\",\n      \"method\": \"X-ray crystallography (2.3 Å), gel filtration, SAXS\",\n      \"journal\": \"Structure\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure with solution validation\",\n      \"pmids\": [\"19141286\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Using MKK3-/-, MKK6-/-, and double-knockout cells, MKK3 and MKK6 are both required for stress-induced p38γ and p38β activation, while MKK6 is the major p38γ activator in response to TNFα; p38δ activation by UV, osmotic shock, anisomycin, and TNFα is mediated selectively by MKK3.\",\n      \"method\": \"MKK knockout fibroblasts, kinase activity assays, phosphorylation of downstream substrate hDlg\",\n      \"journal\": \"Cellular signalling\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic knockout panel with isoform-specific readouts\",\n      \"pmids\": [\"20004242\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"ASK1 phosphorylates MKK6 in response to oxidative stress (H2O2); H2O2 treatment increases ASK1 catalytic efficiency for MKK6 ~4000-fold primarily by decreasing Km(MKK6) ~1000-fold; MKK6 co-purifies within the ASK1 signalosome in a transient, stress-regulated manner.\",\n      \"method\": \"In vitro kinetic analysis, immunoprecipitation, high-molecular mass complex purification from intact cells\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — quantitative in vitro kinetics + cell-based signalosome purification\",\n      \"pmids\": [\"20364819\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"LRRK2 (Parkinson's disease kinase) binds to MKK6 and phosphorylates MKK6 in vitro; co-expression of LRRK2 and MKK6 increases steady-state levels of each protein and increases MKK6 membrane localization; disease-linked LRRK2 mutations (G2019S, R1441C, I2020T) enhance binding to MKK6.\",\n      \"method\": \"Co-immunoprecipitation, in vitro kinase assay, subcellular fractionation, C. elegans RNAi epistasis\",\n      \"journal\": \"Journal of neurochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP + in vitro phosphorylation + in vivo epistasis, single lab\",\n      \"pmids\": [\"20067578\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Constitutively active MKK6 in melanocytes induces dendrite elongation via upregulation of Cdc42 and Rac1 (Rho family GTPases), identifying MKK6 as an upstream regulator of dendricity through this GTPase pathway.\",\n      \"method\": \"Adenovirus-mediated constitutively active MKK6 overexpression, morphometric analysis, Western blot in SK-mel-24 melanoma and primary human melanocytes\",\n      \"journal\": \"Journal of dermatological science\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — overexpression phenotype, no direct MKK6→GTPase phosphorylation shown\",\n      \"pmids\": [\"20869211\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Crystal structure of non-phosphorylated human MAP2K6 complexed with an ATP analogue (2.6 Å) reveals three activation-loop α-helices (AH1, AH2, AH3) that enforce auto-inhibition: AH1 displaces the αC-helix and AH1/AH2 enclose the ATP γ-phosphate, representing a unique auto-inhibition mechanism distinct from MAP2K1 and MAP2K4.\",\n      \"method\": \"X-ray crystallography (2.6 Å), structural comparison\",\n      \"journal\": \"Journal of biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure with mechanistic interpretation\",\n      \"pmids\": [\"22383536\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"β-Amyloid activates MKK6 (phosphorylation at Ser207), which then directly phosphorylates p66shc at Ser36; MKK6 physically associates with p66shc (co-IP), and this MKK6-p66shc complex mediates β-amyloid-evoked ROS production and apoptotic cell death.\",\n      \"method\": \"Co-immunoprecipitation, site-directed mutagenesis, MKK6 knockdown, ROS assay, apoptosis assay\",\n      \"journal\": \"Neuromolecular medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP + mutagenesis + knockdown with defined phenotype, single lab\",\n      \"pmids\": [\"24085465\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"FBXO31, a component of SCF E3 ubiquitin ligase, binds MKK6 and mediates its Lys48-linked polyubiquitination and proteasomal degradation, functioning as a negative regulator of MKK6-p38 signaling upon genotoxic stress.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay (K48-specific), proteasome inhibitor studies, loss-of-function in cancer cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP + ubiquitination assay + functional rescue, single lab\",\n      \"pmids\": [\"24936062\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"TPL-2 (MAP3K8) kinase activity is required for TLR4 and TNF receptor activation of MKK3/6 phosphorylation in macrophages, downstream of IKK-mediated phosphorylation of NF-κB1 p105; established by quantitative mass spectrometry comparing wild-type and kinase-inactive TPL-2 knock-in macrophages.\",\n      \"method\": \"Quantitative phosphoproteomics (mass spectrometry), kinase-inactive knock-in mice, macrophage stimulation assays\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — quantitative phosphoproteomics in genetic model, replicated across multiple TLR stimuli\",\n      \"pmids\": [\"27402796\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"miR-625-3p directly targets MAP2K6 mRNA (validated by luciferase reporter), reducing MAP2K6-p38 signaling and inducing oxaliplatin resistance in colorectal cancer cells; resistance is reversed by anti-miR-625-3p treatment or ectopic expression of a miR-625-3p-insensitive MAP2K6 variant.\",\n      \"method\": \"Luciferase reporter assay, siRNA, dominant-negative MAP2K6, transcriptome/proteome/phosphoproteome profiling, functional rescue\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — luciferase validation + orthogonal rescue experiment + multi-omics confirmation\",\n      \"pmids\": [\"27526785\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"MKK6 is elevated in white adipose tissue of obese individuals; Mkk6 deletion in mice increases thermogenic capacity and UCP1 expression in WAT via T3 stimulation, protecting against diet-induced obesity; mechanistically, p38 is activated in WAT through an alternative pathway involving AMPK-TAK-TAB rather than MKK6.\",\n      \"method\": \"MKK6 knockout mice, shRNA knockdown, UCP1 expression assay, metabolic phenotyping, pathway dissection with specific inhibitors\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic knockout with in vivo metabolic phenotype and mechanistic pathway identification\",\n      \"pmids\": [\"29021624\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"TRIM9 short isoform (TRIM9s) stabilizes MKK6 by promoting K63-linked ubiquitination at Lys82, thereby blocking competing degradative K48-linked ubiquitination at the same lysine; MKK6 in turn stabilizes TRIM9s via p38-dependent phosphorylation at Ser76/80, forming a positive feedback loop that enhances p38 signaling.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay (K48 vs K63 linkage), mutagenesis (Lys82, Ser76/80), phosphorylation assay\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — site-specific ubiquitination and phosphorylation mapping with mutagenesis\",\n      \"pmids\": [\"29669288\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Gossypetin directly inhibits MKK3 and MKK6 protein kinase activity in vitro; Arg61 in MKK6 is critical for gossypetin binding as shown by mutagenesis; inhibition is dependent on MKK3/6 expression in cells.\",\n      \"method\": \"In vitro kinase assay, computational docking, site-directed mutagenesis (R61), cell growth assays\",\n      \"journal\": \"Cancer letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — in vitro kinase assay + mutagenesis, single lab\",\n      \"pmids\": [\"30391783\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Optical activation (uncaging) of MKK6 in fibroblasts is sufficient to trigger p38-dependent apoptosis and potently inhibits ERK/pro-proliferative signaling; the ERK pathway inhibition by MKK6 is equally robust even when all p38 isoforms are pharmacologically inhibited, revealing a p38-independent negative cross-regulatory function of MKK6.\",\n      \"method\": \"Caged lysine light-activatable kinase expression, p38 inhibition, ERK pathway readout, apoptosis assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — novel optogenetic kinase activation with pharmacological dissection of p38-dependent vs -independent effects\",\n      \"pmids\": [\"32371393\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"MKK6 phosphorylates Gatad2b as a novel substrate (independent of p38), promoting K9 histone acetylation and heterochromatin loosening to facilitate somatic cell reprogramming; this requires MKK6 kinase activity but not its canonical p38 target.\",\n      \"method\": \"Overexpression/knockdown during iPSC reprogramming, kinase activity assays, ATAC-seq, ChIP, identification of Gatad2b as MKK6 substrate\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — identification of novel substrate with functional chromatin readout, single lab\",\n      \"pmids\": [\"34815549\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"NMR spectroscopy and ITC define the binding interface between full-length MKK6 and p38: MKK6 engages p38 via the hydrophobic docking groove and influences helix αF; the conserved docking (CD) site of p38 is much less affected by MKK6 than by phosphatases; MKK6 binding is independent of its activation state.\",\n      \"method\": \"NMR spectroscopy, isothermal titration calorimetry (ITC)\",\n      \"journal\": \"Protein science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — structural NMR with thermodynamic validation defines molecular binding interface\",\n      \"pmids\": [\"33554397\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"MKK6 deficiency in mice blunts p38α activation while causing MKK3-p38γ/δ hyperphosphorylation and elevated mTOR signaling, leading to cardiac hypertrophy that progresses to dilatation and fibrosis; cardiac hypertrophy is reversed by p38γ or p38δ knockout or rapamycin treatment, identifying MKK3/6-p38γ/δ-mTOR as a cardiac hypertrophy pathway.\",\n      \"method\": \"MKK6 knockout mice, longitudinal cardiac function analysis, p38γ/p38δ double knockout rescue, rapamycin treatment, kinase assays\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo genetic epistasis with pharmacological rescue, multiple orthogonal validations\",\n      \"pmids\": [\"35971771\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"PPM1G phosphatase directly dephosphorylates MEK6 (phospho-MEK6 identified as direct PPM1G substrate), reducing p38 activation and promoting lung adenocarcinoma proliferation and metastasis.\",\n      \"method\": \"Phosphoproteomics, in vitro dephosphorylation assay, co-immunoprecipitation, loss-of-function in cancer cells\",\n      \"journal\": \"Carcinogenesis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct substrate identification in vitro + functional cellular readout, single lab\",\n      \"pmids\": [\"36349938\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Cryo-EM structure of the MKK6-p38α complex combined with molecular dynamics simulations, HDX-MS, and cell experiments reveals a dynamic multistep dual-phosphorylation mechanism; MKK6's disordered N-terminus determines pathway specificity; catalytically relevant interaction interfaces were identified.\",\n      \"method\": \"Cryo-electron microscopy, molecular dynamics simulation, hydrogen-deuterium exchange mass spectrometry, cell-based assays\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — cryo-EM structure with MD and HDX-MS validation, multidisciplinary approach\",\n      \"pmids\": [\"37708276\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"MAP2K6 (MKK6) is a dual-specificity kinase that functions as the primary upstream activator of p38α, p38β, p38γ, and p38δ MAPKs through dual phosphorylation of their TGY activation loop motif; its cryo-EM structure with p38α reveals a dynamic multistep phosphorylation mechanism where MKK6's disordered N-terminus determines pathway specificity, while its autoinhibited dimeric crystal structure explains how the unphosphorylated enzyme prevents premature activation. MKK6 is itself activated by MAP3Ks including MEKK3, ASK1, and TAK1 in response to stress, cytokines, and dsRNA (via PKR), and is negatively regulated by FBXO31-mediated K48 ubiquitination/degradation, PPM1G dephosphorylation, and p38α-dependent destabilization of its own mRNA. Beyond canonical p38 signaling, MKK6 also phosphorylates non-p38 substrates (Gatad2b, p66shc), interacts with Rac1 to enhance GTPase activity, and exerts p38-independent inhibition of ERK signaling, making it a pleiotropic stress-signaling node controlling inflammation, apoptosis, cell cycle arrest, differentiation, and chromatin remodeling.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"MAP2K6 (MKK6) is a dual-specificity MAP kinase kinase that serves as the primary upstream activator of all four p38 MAPK isoforms (α, β, γ, δ), phosphorylating their TGY activation loop motif in response to diverse stresses, cytokines, and receptor signals relayed through MAP3Ks including MEKK3, ASK1, TAK1, TPL-2, and PKR [PMID:8621675, PMID:9430721, PMID:10347227, PMID:20364819, PMID:15229216, PMID:27402796]. Structural studies reveal that unphosphorylated MKK6 adopts an autoinhibited dimeric conformation with unique activation-loop α-helices that prevent premature activation, while the cryo-EM structure of the MKK6–p38α complex demonstrates a dynamic multistep dual-phosphorylation mechanism in which MKK6's disordered N-terminus determines pathway specificity [PMID:19141286, PMID:22383536, PMID:37708276]. MKK6 activity is negatively regulated by p38α-mediated destabilization of its own mRNA, FBXO31-directed K48-linked ubiquitination and proteasomal degradation, and PPM1G-catalyzed dephosphorylation, while TRIM9s-mediated K63-linked ubiquitination at Lys82 stabilizes MKK6 in a positive feedback loop [PMID:12482988, PMID:24936062, PMID:36349938, PMID:29669288]. Beyond canonical p38 signaling, MKK6 phosphorylates non-p38 substrates including Gatad2b to promote chromatin remodeling during somatic cell reprogramming, directly interacts with Rac1 to modulate GTPase activity, and exerts p38-independent inhibition of ERK signaling, underpinning its roles in inflammation, apoptosis, G2 arrest, thymocyte negative selection, adipogenesis, osteoclastogenesis, chondrogenesis, and cardiac homeostasis [PMID:34815549, PMID:17854274, PMID:32371393, PMID:12151339, PMID:10585441, PMID:35971771].\",\n  \"teleology\": [\n    {\n      \"year\": 1996,\n      \"claim\": \"Identification of MKK6 as a selective p38 MAPK activator resolved the question of which MAP2K relays stress/cytokine signals specifically to p38 rather than ERK or JNK, establishing the specificity principle of MAPK cascades.\",\n      \"evidence\": \"cDNA cloning, co-transfection, and direct in vitro kinase assays in multiple labs; biochemical purification from rabbit skeletal muscle\",\n      \"pmids\": [\"8621675\", \"8626699\", \"8861944\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contributions of MKK6 vs MKK3 to p38 activation in specific tissues were not resolved\", \"Upstream MAP3Ks for MKK6 were unknown\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Demonstration that MKK6 activates p38γ and p38δ (in addition to p38α/β) while MKK3 cannot activate p38β2 established MKK6 as the broadest-spectrum p38 activator and defined isoform-specific coupling rules.\",\n      \"evidence\": \"In vitro kinase assays and co-transfection in COS cells with all four p38 isoforms\",\n      \"pmids\": [\"9029150\", \"9218798\", \"9430721\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether isoform selectivity held in vivo with endogenous expression levels was untested\", \"Structural basis for broader substrate range of MKK6 vs MKK3 was unknown\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Placement of MKK6 downstream of specific receptor systems—Fas, TCR, TNF/RIP/TRAF2, and Gq-coupled receptors—and demonstration that constitutively active MKK6(Glu) confers p38-dependent anti-apoptotic or pro-inflammatory effects established MKK6 as a critical signaling node in immune and cardiac cell biology.\",\n      \"evidence\": \"Dominant-negative MKK6 epistasis, constitutively active MKK6(Glu) gain-of-function, reporter assays, and pharmacological inhibition in T cells, monocytes, endothelial cells, and cardiac myocytes\",\n      \"pmids\": [\"9362518\", \"9575191\", \"9712898\", \"9525929\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct MAP3K→MKK6 phosphorylation was not reconstituted\", \"Endogenous protein-level validation was limited in most systems\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Identification of MEKK3 as a MAP3K that directly phosphorylates and activates MKK6 in vitro filled the gap between upstream signals and MKK6 activation, completing a three-tier MEKK3→MKK6→p38 cascade.\",\n      \"evidence\": \"In vitro kinase assay with immunoprecipitated MEKK3 and recombinant MKK6, cascade reconstitution to MAPKAPK2 in COS-7 cells\",\n      \"pmids\": [\"10347227\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological contexts requiring MEKK3 vs other MAP3Ks for MKK6 activation were unclear\", \"Other MAP3Ks capable of activating MKK6 had not been systematically identified\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Discovery that MKK6–p38γ mediates ATM-dependent G2 arrest after γ-irradiation and that MKK6–p38/MAPKAPK2 phosphorylates αB-crystallin for cytoprotection expanded MKK6 function beyond inflammation to DNA damage response and proteostasis.\",\n      \"evidence\": \"Dominant-negative alleles for MKK6 and p38γ, cell cycle analysis after irradiation, epistasis with ATM; constitutively active MKK6(Glu) in cardiac myocytes with phospho-site mapping\",\n      \"pmids\": [\"10848581\", \"10816593\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct ATM→MKK6 phosphorylation was not shown\", \"Whether p38γ-selective G2 arrest generalizes beyond HeLa cells was untested\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Generation of Mkk6 knockout mice revealed a non-redundant requirement for MKK6 in thymocyte negative selection, distinct from MKK3's role in peripheral T cell apoptosis, establishing in vivo isoform specificity.\",\n      \"evidence\": \"Mkk6−/− and Mkk3−/− mice, thymocyte deletion assays, peripheral T cell death assays\",\n      \"pmids\": [\"12151339\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular basis for MKK6's exclusive role in thymic deletion vs MKK3 in peripheral apoptosis was unknown\", \"Compensatory mechanisms in double-knockout mice were not examined\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Identification of a p38α-mediated negative feedback loop that destabilizes MKK6 mRNA via its 3′UTR revealed autoregulation of MAPK cascade amplitude and explained elevated MKK6 in p38α-null cells.\",\n      \"evidence\": \"p38α−/− MEFs, mRNA stability assays, 3′UTR luciferase reporters, rescue by p38α re-expression\",\n      \"pmids\": [\"12482988\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"RNA-binding protein(s) mediating p38α-dependent MKK6 mRNA decay were not identified\", \"Whether this feedback operates in all tissues was unknown\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Demonstration that PKR directly phosphorylates MKK6 (but not MKK3/4) upon dsRNA stimulation identified a unique MAP3K-like activator linking innate antiviral sensing to p38 signaling.\",\n      \"evidence\": \"In vitro kinase assay, coupled kinase cascade, PKR−/− cells, kinase-inactive PKR dominant-negative\",\n      \"pmids\": [\"15229216\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Phosphorylation sites on MKK6 targeted by PKR were not mapped\", \"Contribution of PKR–MKK6 axis relative to conventional MAP3Ks in vivo was unclear\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Structural analysis of p38α inhibitors showed that DFG-out conformation stabilizers block MKK6-dependent p38α activation by displacing the activation loop, providing mechanistic insight into how substrate conformation gates upstream kinase access.\",\n      \"evidence\": \"Crystal structures of seven p38α-inhibitor complexes, cell-free MKK6-dependent p38α activation assay, cellular TNFα inhibition\",\n      \"pmids\": [\"16342939\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No co-crystal of MKK6 with p38α was available at this time\", \"Whether DFG-out inhibitors affect MKK6 interaction with other p38 isoforms was not tested\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"MKK6 was found to interact directly with Rac1 and modulate its GTPase activity, and to recruit SWI/SNF chromatin remodelers to muscle gene promoters via p38, expanding MKK6's roles beyond canonical MAPK signaling to include GTPase regulation and chromatin remodeling.\",\n      \"evidence\": \"Co-IP of MKK6–Rac1, Y219F mutagenesis, NADPH oxidase assays in MKK6−/− tissue; ChIP for SWI/SNF complex on muscle gene promoters with p38 pathway perturbation\",\n      \"pmids\": [\"17854274\", \"17964260\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether MKK6 phosphorylates Rac1 directly was not established\", \"Whether SWI/SNF recruitment requires direct p38-mediated phosphorylation of SWI/SNF subunits was untested\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"The crystal structure of the MKK6 kinase domain revealed an autoinhibited elongated dimer whose interface occludes the activation loop, explaining how MKK6 prevents spurious activation and providing the first atomic model of a MAP2K autoinhibitory mechanism.\",\n      \"evidence\": \"X-ray crystallography at 2.3 Å (phosphomimetic DD mutant), SAXS confirmation of dimer in solution\",\n      \"pmids\": [\"19141286\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How MAP3K binding disrupts the autoinhibitory dimer was unknown\", \"Whether the dimer exists under physiological concentrations in cells was not shown\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Quantitative kinetics of ASK1-mediated MKK6 phosphorylation showed that oxidative stress increases ASK1's catalytic efficiency for MKK6 ~4000-fold (primarily by decreasing Km ~1000-fold), revealing a stress-regulated substrate recruitment mechanism within the ASK1 signalosome.\",\n      \"evidence\": \"In vitro kinetic analysis, immunoprecipitation, high-MW signalosome purification from H2O2-treated cells\",\n      \"pmids\": [\"20364819\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of adaptor proteins mediating stress-dependent Km reduction was unknown\", \"Whether similar kinetic regulation applies to other MAP3K–MKK6 pairs was untested\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"A second MKK6 crystal structure (non-phosphorylated, ATP-analogue-bound) revealed three unique activation-loop α-helices (AH1–AH3) that enforce autoinhibition by displacing αC-helix and sequestering the ATP γ-phosphate, establishing a distinct autoinhibitory mechanism from other MAP2Ks.\",\n      \"evidence\": \"X-ray crystallography at 2.6 Å, structural comparison with MAP2K1 and MAP2K4\",\n      \"pmids\": [\"22383536\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How upstream phosphorylation unfolds the AH1–AH3 helices was not resolved\", \"No structure of MAP3K-bound MKK6 existed\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Identification of FBXO31-mediated K48-linked polyubiquitination as a degradation pathway for MKK6 established ubiquitin-proteasome regulation as a mechanism controlling MKK6 protein levels during genotoxic stress.\",\n      \"evidence\": \"Co-IP, K48-specific ubiquitination assay, proteasome inhibitor rescue, functional assays in cancer cells\",\n      \"pmids\": [\"24936062\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Specific lysine residue(s) ubiquitinated by FBXO31 were not mapped\", \"In vivo validation in knockout models was lacking\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Mkk6 deletion in mice increased white adipose tissue thermogenesis and UCP1 expression, protecting against diet-induced obesity, revealing MKK6 as a negative regulator of adaptive thermogenesis—an unexpected role given its canonical p38-activating function.\",\n      \"evidence\": \"MKK6 knockout mice, metabolic phenotyping, UCP1 expression analysis, pathway dissection showing p38 activation via alternative AMPK–TAK–TAB pathway in WAT\",\n      \"pmids\": [\"29021624\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether MKK6's thermogenic suppression is cell-autonomous in adipocytes vs systemic was not fully resolved\", \"Direct mechanism by which MKK6 suppresses UCP1 was not identified\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Discovery that TRIM9s stabilizes MKK6 via K63-linked ubiquitination at Lys82, competing with degradative K48-linked ubiquitination at the same residue, while MKK6/p38 reciprocally stabilizes TRIM9s, revealed a positive feedback circuit controlling p38 pathway amplitude.\",\n      \"evidence\": \"Co-IP, K48 vs K63 linkage-specific ubiquitination assays, Lys82 mutagenesis, phospho-site mapping (Ser76/80) on TRIM9s\",\n      \"pmids\": [\"29669288\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether this feedback operates in all tissues or is context-specific was unknown\", \"Other E3 ligases mediating K48 ubiquitination at Lys82 beyond FBXO31 were not identified\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Optogenetic activation of MKK6 demonstrated that MKK6 inhibits ERK signaling with equal potency regardless of p38 inhibition, establishing a p38-independent cross-regulatory function of MKK6 between the p38 and ERK MAPK pathways.\",\n      \"evidence\": \"Light-activated (caged lysine) MKK6, pharmacological inhibition of all p38 isoforms, ERK phosphorylation readout, apoptosis assay\",\n      \"pmids\": [\"32371393\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct molecular target through which MKK6 inhibits ERK was not identified\", \"Whether this cross-regulation occurs at a MAP3K, RAF, or MEK1/2 level was unknown\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Identification of Gatad2b as a direct, p38-independent MKK6 substrate linked MKK6 kinase activity to chromatin remodeling (H3K9 acetylation, heterochromatin loosening) during somatic cell reprogramming, expanding MKK6's substrate repertoire beyond p38.\",\n      \"evidence\": \"Kinase assays, ATAC-seq, ChIP for H3K9ac, iPSC reprogramming efficiency with MKK6 overexpression/knockdown\",\n      \"pmids\": [\"34815549\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Phosphorylation sites on Gatad2b targeted by MKK6 were not fully mapped\", \"Independent replication of Gatad2b as a direct substrate is needed\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"MKK6 deficiency in mice caused compensatory MKK3–p38γ/δ hyperactivation and mTOR-dependent cardiac hypertrophy reversible by rapamycin, revealing that the MKK6/MKK3 balance controls p38 isoform signaling output with pathological consequences for the heart.\",\n      \"evidence\": \"MKK6 knockout mice, longitudinal echocardiography, p38γ/δ double-knockout rescue, rapamycin treatment\",\n      \"pmids\": [\"35971771\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How MKK6 loss causes MKK3–p38γ/δ hyperactivation mechanistically was not determined\", \"Whether cardiac hypertrophy depends on cardiomyocyte-autonomous MKK6 loss was not tested with conditional knockouts\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"The cryo-EM structure of the MKK6–p38α complex, combined with HDX-MS and MD simulations, revealed a dynamic multistep dual-phosphorylation mechanism and showed that MKK6's disordered N-terminus determines pathway specificity, providing the first high-resolution view of a MAP2K–MAPK catalytic complex.\",\n      \"evidence\": \"Cryo-EM, molecular dynamics simulation, hydrogen-deuterium exchange mass spectrometry, cell-based assays\",\n      \"pmids\": [\"37708276\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structures of MKK6 complexed with p38β/γ/δ are not available\", \"Mechanism by which the N-terminus discriminates p38 from ERK/JNK substrates at atomic resolution is incompletely resolved\", \"No structure of an activated MAP3K–MKK6 complex exists\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Major unresolved questions include: the molecular target through which MKK6 inhibits ERK signaling independently of p38; whether MKK6's autoinhibitory dimer is disrupted by MAP3K binding or other mechanisms in cells; the full scope of non-p38 MKK6 substrates; and the structural basis for MKK6 vs MKK3 isoform selectivity toward p38 family members.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct p38-independent MKK6 target in ERK pathway not identified\", \"No MAP3K–MKK6 co-structure available\", \"Comprehensive substrate profiling not performed\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 1, 2, 3, 19, 34, 42, 46]},\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [0, 1, 8, 30]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [28, 33]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 1, 2, 3, 8, 30, 46]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [6, 16, 22, 36]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [4, 5, 41]},\n      {\"term_id\": \"R-HSA-8953897\", \"supporting_discovery_ids\": [11, 17, 30]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [10, 26]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [24, 42]}\n    ],\n    \"complexes\": [\n      \"ASK1 signalosome\"\n    ],\n    \"partners\": [\n      \"MAPK14\",\n      \"MAPK12\",\n      \"MAPK11\",\n      \"MAP3K5\",\n      \"MAP3K3\",\n      \"TRIM9\",\n      \"FBXO31\",\n      \"RAC1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}